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Edel sei der Mensch,  
Hilfreich und gut!  
Denn das allein  
Unterscheidet ihn  
Von allen Wesen,  
Die wir kennen. 
 
- Johann Wolfgang von Goethe, Das Göttliche 
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whenever he was under its influence, he knew the secret of the universe,  
but when he came to, he had forgotten it.  
 
At last with immense effort, he wrote down the secret before the vision faded.  
When completely recovered he rushed to see what he had written.  
It was "A smell of petroleum prevails throughout." 
 
- Bertrand Russell, A History of Western Philosophy 
 
 
 
 

ABSTRACT 
 
Conformational Analysis of 4-Azidoproline Derivatives  
and their Application in Molecular Recognition 
 
Louis-Sebastian Sonntag 
 
 
This thesis presents studies on the influence of 4-azido-substitutents in azidoproline on the 
conformation of the pyrrolidine ring system as well as the conformation around the peptide 
bond in acetylated monomers and dimers. The azido-group may be reduced to an amine, 
which allows for further modifications. The insights gained were applied to the synthesis of a 
tripodal molecular scaffold. This scaffold was used as a backbone for a synthetic receptor, 
which binds peptides in aqueous solution. 
In the first part of this thesis the effect of the azido-substituent on the conformation of 
4-azidoproline is described. By NMR-spectroscopy, X-ray diffraction, FT-IR spectroscopy 
and ab initio calculations, the conformation of 4-azidoproline derivatives was analyzed. 
Particular focus was laid on the s-cis:s-trans ratio and the factors influencing it. Furthermore, 
the kinetics of the interconversion of the s-cis and s-trans conformation of diastereomeric 
4-azidoproline derivatives were determined by EXSY-NMR.  
The second part of this thesis describes the synthesis and structural analysis of the 
azido-functionalized cyclotriproline and its application as a molecular scaffold for a peptide 
receptor. The binding properties were analyzed in on-bead screenings against an encoded 
tripeptide library in different buffer solutions. The binding affinity to a selected peptide was 
measured by isothermal titration calorimetry (ITC).  
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1 Introduction 
In nature, the function of a molecule depends largely upon its conformation. This holds 
true for nature's largest molecules such as DNA and proteins, as well as for its relatively 
small molecules, such as peptides (both linear and cyclic) or polyketides among many 
others. As these molecules are typically only active in a specific conformation, 
understanding the factors that control the conformation of relatively small molecules is 
of great importance. While proteins have secondary, tertiary and even quaternary 
structural elements controlling their conformation, the conformation of small molecules 
is controlled by more elementary, structure-inherent effects.  
A basic principle nature applies to control the conformation of small molecules is by 
covalently restricting the conformation, for instance by cyclization. Cyclization to 
cyclic or even polycyclic systems, restricts the conformational flexibility of molecules, 
leading to more rigid, conformationally defined structures. A well-known example 
illustrating this principle is Vancomycin, a glycopeptidic antibiotic isolated from 
Amycolatopsis orientalis.[1]  
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Figure 1: Vancomycin and its target sequence. 
The efficiency of Vancomycin is highly dependent upon its conformation. The 
vancomycin skeleton (figure 1) consists of three interlocked cyclic tripeptides which 
collectively afford a conformationally rigid cup-shaped structure.[2] Small changes in 
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the structure of Vancomycin lead to less active or even inactive compounds. Due to the 
perfect alignment of hydrogen donor and acceptor sites on the molecule, Vancomycin 
binds its target sequence UDP-N-acetylmuramyl-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala-OH 
with a binding constant of 1.6×10-5 M-1 (or a dissociation constant of 62.5µM).[3] 
 
In the realm of the polyketides, nature uses two major principles to destabilize 
undesired conformations: one is to avoid 1,3-allylic strain and the other is to avoid 
syn-pentane interactions.[4,5,6] 
CH3
CH3
CH3H  
Figure 2: Preferred conformation of a 1,1-disubstituted allylic system (left) and of a pentane destabilized 
by a syn-pentane interaction (right). 
The destabilizing syn-pentane interaction is created when a hydrocarbon chain is folded 
in such a way that the terminal methyl groups are in gauche conformations to the 
backbone. This brings the methyl groups into close proximity, similar to the 1,3-diaxial 
arrangement in substituted cyclohexanes. Thus, the conformation shown in figure 2 on 
the right is energetically unfavorable and will be avoided if possible. In contrast, the 
1,1-disubtituted allylic system shown in figure 2 on the left is a low energy 
conformation and will be adopted if possible. Using these basic principles, nature 
controls the conformation of seemingly flexible molecules. One example is Zincophorin 
1, an ionophore antibiotic isolated from a strain of Streptomyces griseus.[7,8]  
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OH OH OH
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Figure 3: The ionophore antibiotic Zincophorin. 
The conformation of Zincophorin is governed by avoidance of 1,3 allylic strain (in the 
part of the molecule marked "Part A" in figure 3) and syn-pentane interactions (in the 
part of the molecule marked "Part B" in figure 3). Hoffmann and coworkers have shown 
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that the careful placement of the methyl groups along the backbone of hydrocarbon and 
polyketide natural products renders them "flexible molecules with a defined shape".[9]  
 
These examples illustrate some of the ways in which nature controls the conformation 
of small molecules. These conformation-directing elements have been applied to control 
the stereochemical outcome of organic reactions,[10a-c] in the total synthesis of natural 
products,[10d] as well as in the design of structurally defined small molecules.[10e] 
Hoffmann and coworkers have demonstrated, that with the principles of the allylic 
strain and the syn-pentane interaction, a mimic for the βII-hairpin can be designed 
(figure 4).[10e] 
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Figure 4: βII-hairpin-mimic A and natural βII-hairpin B. 
Using the same principles, Still and coworkers designed podand ionophores (figure 
5).[11] Even though the molecule shown in figure 5 could principally form many 
conformers, by careful placement of methyl groups, the undesired conformations are 
destabilized through syn-pentane interactions. Thus, only one low energy conformation 
is found.[11f] 
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Figure 5: General structure of podand ionophores, X=CH2, O, S or SO2. 
Still and coworkers showed that podands of this type are chiral analogs of 18-crown-6 
and allow for highly enantioselective binding of the protonated N-terminus of amides 
and esters of amino acids, due to their highly defined structure. For example, a podand 
of the class shown in figure 5, in which X=SO2 binds amides and esters of α-amino 
acids with enantioselectivities as high as 80% ee.[11]  
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Peptides can adopt secondary structure motifs such as α-helices, β-sheets and turn 
conformations. Furthermore, there are polyproline helices as found in collagen. With 
the exception of the polyproline helices, the stabilization of these secondary structure 
elements relies upon hydrogen bonding interactions and the number of residues needed 
to form these structures is typically larger than 5.[12] At a more basic level, the 
conformation of peptides is also governed by the principles shown above: Syn-pentane 
interactions and 1,3-allylic strain.  
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Figure 6: Mesomeric structures of an amide bond (left) and analogous allylic system (right). 
The amide bond has two mesomeric structures, shown in figure 6 on the left. By 
comparison to 2,4-dimethylpent-2-ene shown on the right, it can be seen that the ionic 
mesomeric structure is analogous to the allylic systems discussed earlier. Likewise, the 
conformational preference is similar to the allylic systems discussed. The conformation 
of the peptide backbone is described by three dihedral angles, φ, ψ and ω (see figure 6). 
Taking the 1,3-allylic strain and the syn-pentane interactions into account, a peptide is 
ideally arranged when its backbone dihedral angles φ and ψ alternate between +120° 
and -120°.[12] 
Due to the mesomeric structures shown in figure 6, ω can only take the value of 0 or 
180°, which are referred to as s-cis and s-trans, respectively (figure 7). In most peptide 
bonds, the s-trans conformer is greatly favored over the s-cis conformer. 
R1
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N
R2
O
O
H
N
R2
R1
s-trans s-cis  
Figure 7: s-trans versus s-cis conformation in a peptide bond. 
Among the natural amino acids, proline is special. It is the only cyclic proteinogenic 
amino acid and the only one with a secondary amine. Furthermore, it differs from the 
other amino acids in its conformational preference. In all other amino acids for steric 
reasons, the amide bond is found almost exclusively in the s-trans (ω = 180°) 
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conformation. A survey of 571 protein structures found 0.03% of Xaai-1-nonProi peptide 
bonds to be in the s-cis. In contrast, the Xaai-1-Proi bond was found to be in the s-cis 
conformation (ω = 0) in 5.2% of the peptide bonds of the proteins studied.[13, 14] 
The cis-proline conformation plays an important role in the folding and the activity of 
proteins. An example, in which a cis-proline is an important for the folding of enzymes, 
is the class of the glutathione S-transferases. In this class of enzymes, a cis-proline unit 
mediates a sharp turn between an α-helical part of the protein and a β-strand, essential 
for its conformational stability and activity.[15] Bovine prothrombine is an example, in 
which the change from a trans-proline to a cis-proline is a switch for the activity of the 
protein. The binding of calcium leads to isomerization of a trans-proline to a cis-proline 
bond, inducing bovine prothrombine to assume its active, membrane-binding 
conformation.[16] Furthermore, proline cis/trans isomerizations have been identified as 
the rate-limiting step in the folding of many proteins.[17] For some proteins the correct 
conformation is achieved with the help of peptidylproline cis/trans isomerases 
(PPIases), a class of enzymes, which also plays an important role in the immune 
response.[18] 
 
Apart from proline itself, a variety of proline derivatives are found in nature. Both 
dehydrogenated, as well as mono- and polysubstituted proline derivatives have been 
found (figure 8).[19] In many cases, the proline derivatives themselves, or peptides 
containing them, display antibiotic, neurotoxic or anti-tumor activity. The most 
common proline derivative is (4R)-hydroxyproline 3, which is a major component of 
collagen and was first discovered in gelatin hydrolysates in 1902.[20] Collagen is an 
abundant triple-helical structure protein. In collagen, free hydroxyproline is not 
incorporated directly, instead proline is converted to hydroxyproline after its 
incorporation into the peptide chain.[21] 3-Hydroxyproline 4 was first isolated from 
hydrolysates of mediterranean sponge,[22] and was later also found in human urine, 
resulting from collagen metabolism.[23] Moreover, many members of the class of the 
actinomycin antibiotics[24] also contain (4R)-hydroxyproline 3,[25] as well as 
4-ketoproline 6,[26,27] 3-hydroxy-5-methylproline 5[28,29] or 5-methylproline 2.[27,30]  
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Figure 8: Natural proline derivatives. 
Both diastereoisomers of 3-methylproline 8[31] and 9[32,33] are known, both as part of 
cyclic peptides, and even cis-3,4-methano-L-proline 10[34] has been isolated. Another 
noteworthy member of the proline derivatives is kainic acid 7,[35] which is a 
neurotoxin,[36] by a neurotransmitting effect mediated through glutamate receptors. It is 
a conformationally restricted analog of glutamic acid, which has been found to be the 
molecular basis for its activity.[37] By administration of kainic acid 7, an animal model 
of Huntington's chorea in rats was generated.[38] 
Non-natural proline derivatives have been developed as mimics of proline and 
hydroxyproline. It would be interesting to lock the Xaai-1-Proi bond in an s-cis 
conformation to analyze its influence on the folding process. For example, 
5,5'-dimethylproline (dmP) 11[39,40] (figure 9) was developed as a proline mimic, which 
locks the s-cis conformation of the peptide bond N-terminal to it.  
N
H
CO2H
11  
Figure 9: 5,5'-dimethylproline (dmP) 11. 
This was studied with the tripeptide sequences Tyr-Pro-Asn and Asn-Pro-Tyr, of 
Bovine pancreatic nulclease A, in which the Xaai-1-Proi bond is in the s-cis 
conformation in the native form. 5,5'-dimethylproline was incorporated into these two 
tripeptide fragments and it was shown that for the Tyr-dmP-Asn peptide, the s-cis 
conformation of the Tyr-dmP bond was stable over a temperature range of 6 to 60°C.[41] 
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Scheme 1: Synthesis of ΨPro; X = O or S, R = H or CH3, R', R'' = aryl, alky. 
Another type of proline mimics are the pseudo-prolines (ΨPro). These analogs derive 
from serine, threonine and cysteine, which can be converted to (4S)-oxazolidine- and 
(4R)-thiazolidine-carboxylic acid, respectively (scheme 1).[42] They can be used as 
protected forms of the amino acids they derive from, as the oxazolidine- and 
thiazolidine rings can be cleaved after peptide synthesis.[42a] In peptide synthesis, the 
use of pseudo-prolines helps to facilitate the synthesis by their capability to break 
aggregates, self-association, and β-sheet-like structures, thus improving the solubility of 
the growing in peptide chain.[43] Furthermore, depending on the steric demand of the 
substituents R' and R'', the population of the s-cis conformation can be increased up to 
>99%.[44]  
N
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CO2H N
H
CO2H
F F
12 13  
Figure 10: (4S)- and (4R)-fluoroproline 12 and 13 (left and right, respectively). 
Another approach to modify proline to control the local conformation is the introduction 
of a fluoro-substituent at the 4-position (figure 10). Unlike 5,5'-dimethylproline 11 or 
the pseudo-prolines, the conformation of the 4-fluoroprolines 12 and 13 is not mainly 
influenced by steric effects, but by stereoelectronic effects.[45] The inductive effect of 
the electronegative substituent at the 4-position influences the equilibrium between the 
s-cis and s-trans conformation in dependence of the configuration at C(4).[46, 47] 
 
This thesis presents studies on the influence of 4-azido-substitutents in azidoproline on 
the conformation of the pyrrolidine ring system as well as the conformation around the 
peptide bond in acetylated monomers and dimers. The azido-group may be reduced to 
an amine, which allows for further modifications. The insights gained were applied to 
the synthesis of a tripodal molecular scaffold. This scaffold was used as a backbone for 
a synthetic receptor, which binds peptides in aqueous solution. 
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In the first part the effect of a 4-azido-substituent on the conformation of azidoproline is 
described. By NMR-spectroscopy, X-ray diffraction, FT-IR spectroscopy and ab initio 
calculations, the conformation of 4-azidoproline derivatives was analyzed. Particular 
focus was laid on the s-cis:s-trans ratio and the factors influencing it. Furthermore, the 
kinetics of the interconversion of the s-cis and s-trans conformation of diastereomeric 
4-azidoproline derivatives were determined by EXSY-NMR.  
The second part of this thesis describes the synthesis and structural analysis of the 
azido-functionalized cyclotriproline and its application as a molecular scaffold for a 
peptide receptor. The binding properties were analyzed in on-bead screenings against an 
encoded tripeptide library in different buffer solutions. The binding affinity to a selected 
peptide was measured by isothermal titration calorimetry (ITC).  
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2 Conformational Analysis of Azidoproline 
Derivatives 
2.1 Introduction 
Previous studies have shown that the tendency for the formation of a diketopiperazine 
of 4-azidoproline is dependent on the configuration at the C(4)-position, on which the 
azide resides.[48] When the configuration is (4S), an activated ester of azidoproline 
reacts to form the diketopiperazine in a one-pot reaction in 47% yield (scheme 2a). 
However, when the configuration is (4R), the same reaction conditions yield less than 
5% of the desired product (scheme 2b).[49] 
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Scheme 2: Diketopiperazine formation in dependence of the configuration at C-4. 
The diketopiperazine of (4R)-configured azidoproline can be formed; however, the 
linear dipeptide precursor needs to be formed first (scheme 3).[50] 
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79%
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Scheme 3: Diketopiperazine formation of di[(4R)-azidoproline] methyl ester. 
NMR studies revealed that the diketopiperazine derived from (4R)-configured 
azidoproline is rigid and possesses a single favorable conformation, with the 
azido-group occupying the pseudo-axial conformation. In contrast, the diketopiperazine 
derived from (4S)-azidoproline is more flexible and shows a fast equilibrium between 
conformations with azido-substituent in the pseudo-axial and pseudo-equatorial 
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positions.[51] These results indicate that the configuration of the C(4)-position of 
azidoproline influences the conformation of the pyrrolidine ring system. Furthermore, 
the different cyclization tendencies indicate that the s-cis:s-trans equilibrium is also 
influenced by the configuration at C(4). 
Therefore, the influence of the azido-substituent and the configuration at C(4) on the 
conformation of 4-azidoproline was studied. The 4-azidoproline derivatives 14-21 
(figure 11) were prepared for this study. 
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Figure 11: Acetylated 4-azidoproline derivatives studied. 
Initially, the s-cis:s-trans ratio of the methyl ester derivatives 14 and 15 were 
determined by 1H-NMR (chapter 2.3.1). Consequently, the influence of the C-terminal 
modification was analyzed by comparison with the amide derivatives 16-19 (chapter 
2.3.2). Furthermore, the influence of the N-terminal modification was analyzed by 
comparison of the acetyl-derivatives 14-19 with the dipeptides 20 and 21 (chapter 
2.3.3). To further probe the influence of the azido-substituent, the conformation of the 
pyrrolidine ring systems, 14 and 15 were analyzed by interpretation of the 3J(H-H) 
coupling constants, as well as COSY, TOCSY and NOESY experiments in various 
solvents (chapter 2.4.). Furthermore, crystal structure analysis, IR-spectroscopy and ab 
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inito calculations were performed (chapter 2.5). Finally, the kinetics of the s-cis:s-trans 
isomerization in 14 and 15 were determined by 2D EXSY NMR (chapter 2.6). 
2.2 Synthesis of acetylated 4-azidoproline derivatives 
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a) i) Cs2CO3 (0.55 eq), MeOH, H2O, r.t., 10 min.; ii) MeI (2 eq), DMF, r.t., 60 min., quant.; b) i) 
CH3SO2Cl (1.5 eq), NEt3 (3 eq), CH2Cl2, 0°C, 30 min.; ii) NaN3 (5 eq), DMF, 80°C, 3h, quant.; c) i) 4M 
HCl in dioxane, r.t., 30 min.; ii) Ac2O (2 eq), NEt3 (3 eq), CH2Cl2, r.t., 95%; d) i) CH3SO3H, PPh3, 
DIAD, NEt3, Toluene, 35°-70°C, 3h; ii) NaN3, DMF, 80°C, 3h, 80%; e) i) 4M HCl in dioxane, r.t., 30 
min.; ii) Ac2O (2 eq), NEt3 (3 eq), CH2Cl2, r.t., 95%. 
Scheme 4: Synthesis of acetyl-(4S)-azidoproline methyl ester 14 and acetyl-(4R)-azidoproline methyl 
ester 15. 
The synthesis started from commercially available N-α-Boc-(4R)-hydroxyproline 22, 
which was converted into its methyl ester 23. The hydoxy-group of N-α-Boc-(4R)-
hydroxyproline methyl ester 23 was activated as the mesylate and reacted in an 
SN2-reaction with sodium azide under inversion of configuration at C(4) to yield the 
N-α-Boc-(4S)-azidoproline methyl ester 24. Boc-deprotection and acetylation led to 
acetyl-(4S)-azidoproline methyl ester 14. To obtain the acetylated methyl ester with 
opposite stereochemistry at C(4), N-α-Boc-(4R)-hydroxyproline methyl ester 23 was 
converted in a Mitsunobu reaction to the mesylate 25 under inversion of configuration 
at C(4). The mesylate 25 was reacted without further purification under inversion of 
configuration with sodium azide, yielding N-α-Boc-(4R)-azidoproline methyl ester 26. 
Boc-deprotection and acetylation led to acetyl-(4R)-azidoproline methyl ester 15 
(scheme 4). 
 
 
2.2  Synthesis of acetylated 4-azidoproline derivatives 15 
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a) i) NaOH (2 eq), H2O, THF, MeOH, r.t., 1h; ii) C6F5OH (1.1 eq), EDC (1.5 eq), CH2Cl2, r.t., 1.5h, 
85%; b) HNMe2·HCl (10 eq), NEt3 (10 eq), CH2Cl2, r.t., 10 min.; 87%; c) pyrrolidine (2 eq), CH2Cl2, r.t., 
quant.; d) i) 4M HCl in Dioxane, r.t., 95%; ii) Ac2O, NEt3, CH2Cl2, r.t., 80%. 
Scheme 5: Synthesis of acetylated 4-azidoproline amide derivatives. 
The amide modified acetylated proline derivatives 16 and 18 were synthesized (scheme 
5) starting from Boc[Pro-(4S)-N3]OCH3 24, which was converted into the 
pentafluorophenol ester 27, which in turn was either reacted with dimethylamine 
hydrochloride yielding the dimethyl amide 28 or with pyrrolidine yielding the 
pyrrolidine amide 29. The Boc-protected amide derivatives 28 and 29 were converted to 
their acetyl derivatives 16 and 18, respectively, by Boc-deprotection followed by 
acetylation with acetic anhydride in the presence of triethylamine. The diastereomeric 
acetylated (4R)-azidoproline amide derivatives 17 and 19 (figure 11) were synthesized 
analogously starting from the (4R)-configured methyl ester 26.  
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a) i) NaOH (2 eq), H2O, THF, MeOH, r.t., 1h; ii) C6F5OH (1.1 eq), EDC (1.5 eq), CH2Cl2, r.t., 1.5h, 
85%; b) 4M HCl in dioxane, r.t., 30 min., 95%; c) iPr2NEt (4.4eq), CH2Cl2, r.t., 12h, 88%; d) i) 4M HCl 
in dioxane, r.t., 95%; ii) Ac2O, NEt3, CH2Cl2, r.t., 80%. 
Scheme 6: Synthesis of acetyl-di[(4S)-azidoproline]OCH3 20. 
The synthesis of acetyl-di[(4S)-azidoproline]OCH3 20 (scheme 6) commences from 
N-α-Boc-(4S)-azidoproline methyl ester 24 which was on the one hand converted into 
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the pentafluorophenyl ester 27, and on the other hand, Boc-deprotected to the 
hydrochloride salt 30. The pentafluorophenyl ester 27 and the hydrochloride salt 30 
were reacted with each other to form the dipeptide 31. Boc-deprotection and  
acetylation lead to acetyl-di[(4S)-azidoproline]OCH3 20. The diastereomeric 
acetyl-di[(4R)-azidoproline]OCH3 21 was synthesized analogously. 
 
2.3 Analysis of the s-cis:s-trans ratio of 14-21 
To study the dependence of the s-cis:s-trans equilibrium on the configuration of the 
C(4)-position of the 4-azidoproline derivatives, the relative populations of the s-cis and 
s-trans conformers of the (4S)-derivatives 14, 16, 18 and 20 and the (4R)-derivatives 15, 
17, 19 and 21 (figure 11) were determined by 1H-NMR. The 1H-NMR spectra of all 
derivatives show two seperate six-spin systems corresponding to the protons of the 
pyrrolidine ring in the s-cis and the s-trans conformation. 2D NOE spectroscopy was 
used to assign the conformation of the two spin systems. Integration of the peaks in the 
1H-NMR yielded the relative populations. 
2.3.1 Analysis of the s-cis:s-trans ratio in the methyl ester derivatives 14 and 15 
Initially, the relative population of the s-trans and the s-cis conformation of the methyl 
ester derivatives 14 and 15 was determined in various solvents (table 1). 
Table 1: s-cis:s-trans ratios of 14 and 15 compared to Ac-Pro-OCH3 as determined by 1H-NMR.  
14 15 Ac-Pro-OCH3 
Entry Solvent s-cis:s-trans s-cis:s-trans s-cis:s-trans 
1 D2O 1:2.5 1:6 1:5 
2 DMF-d7 1:1.5 1:4.5 1:3.6 
3 pyridine-d6 1:2 1:4.5 n.d.a 
4 acetone-d6 1:2 1:4 1:3.5 
5 CDCl3 1:2 1:4 1:3.7 
6 dioxane-d8 1:2 1:4 n.d.a 
All samples were measured at 295K and 80 mM concentration. a) "n.d.": not determined. 
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As expected, in both diastereoisomers 14 and 15, the s-trans conformation is favored 
(table 1). The comparison of the s-cis:s-trans ratio shows that the (4R)-configured 
diastereoisomer 15 displays a higher preference for the s-trans conformation than the 
(4S)-configured diastereoisomer 14. Generally, the acetyl-(4R)-azidoproline methyl 
ester 15 favors the s-trans conformation by a factor of 2-3 compared its 
(4S)-diastereoisomer 14. Furthermore the largest difference between 14 and 15 is 
observed in water and DMF (table 2, entries 1 and 2). The typical ratio found for 15 is 
1:4; for 14 the typical ratio is 1:2. For 14, in DMF an almost even distribution of the 
two conformations is observed (table 1, entry 2). The comparison to acetylated proline 
methyl ester demonstrates that the s-cis:s-trans ratio of (4S)-azidoproline 14 lies further 
to the side of the s-cis conformer, while it lies more to the side of the s-trans 
conformation for (4R)-azidoproline 15. This shows that the configuration at C(4) has a 
distinct influence on the s-cis:s-trans ratio of acetyl 4-azidoproline methyl ester. 
2.3.2 Analysis of the s-cis:s-trans ratio in the amide derivatives 16-19 
The studies presented thus far have all been performed with 4-azidoproline methyl ester 
derivatives. To test the influence of the methyl ester, the amide derivatives 16-19 (figure 
11) were analyzed. As the studies described in chapter 2.3.1 found the largest influence 
on the s-cis:s-trans ratio in DMF-d7, this solvent was used for the NMR-spectroscopical 
analysis of the amide derivatives 16-19 (table 2).  
Table 2: s-cis:s-trans ratio of acetylated 4-azidoproline amide derivatives in DMF-d7, 80 mM. 
Entry  Compound s-cis to s-trans ratio 
1 16 1:2 
2 17 1:2 
3 18 1:2 
4 19 1:2 
 
Intriguingly, in DMF both diastereoisomers of the dimethyl amide derivatives 16 and 17 
as well as both diastereoisomers of the pyrrolidine amide derivatives 18 and 19, show 
the same s-cis to s-trans ratio (table 2). This clearly indicates that the higher preference 
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for the s-trans conformation found in acetyl-(4R)-azidoproline methyl ester 15 is 
dependent on the C-terminal ester function. 
2.3.3 Analysis of the s-cis:s-trans ratio in the dipeptides 20 and 21 
To test whether the preferences for the ratio of s-cis:s-trans described in the previous 
chapters are dependent on the acetyl group, the acetylated diproline derivatives 20 and 
21 were studied by NMR spectroscopy in DMF-d7.  
The 1H-NMR spectra of 20 and 21 show four sets of signals, indicating the presence of 
four different conformers. Based on NOESY experiments, these conformers were 
assigned as the s-trans/s-trans, s-trans/s-cis, s-cis/s-trans and s-cis/s-cis conformations 
(scheme 7).  
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Scheme 7: The four possible conformers of acetyl-di[(4S)-azidoproline]OCH3. The arrows indicate the 
positions of protons that show an NOE with each other, indicative of the conformation. 
An NOE between the protons of the acetyl group and the protons at C(δ) is indicative of 
an s-trans conformation of the N-terminal amide bond (scheme 7, left). Conversely, an 
NOE between the protons of the acetyl group and the proton at C(α) indicates an s-cis 
conformation (scheme 7, right). The s-trans conformation of the central amide bond 
was assigned based on an NOE between the proton at C(α) of the N-terminal 
4-azidoproline and the proton at C(δ) of the C-terminal 4-azidoproline (scheme 7, top). 
In the s-cis conformation of the central amide bond, an NOE between the two protons at 
the C(α) positions of the two 4-azidoprolines was observed (scheme 7, bottom). 
2.3  Analysis of the s-cis:s-trans ratio of 14-21 19 
Table 3: Population of conformations in 20 and 21, listed for each amide bond.  
Entry N-terminal Central 20 21 
1 s-trans s-trans 21 22 
2 s-cis s-trans 8 8 
3 s-trans s-cis 1 1 
4 s-cis s-cis 4 1 
Measurements at 80 mM concentration in DMF-d7, 295K. 
By integration of the 1H-NMR signals corresponding to the different conformers, the 
relative population of each of the conformers was determined. The relative populations 
of the s-trans/s-trans, s-trans/s-cis and s-cis/s-trans conformations were found to be 
equal in both diastereoisomers, 20 and 21 (table 3, entries 1-3). However, 20 shows a 
4-fold higher population of the s-cis/s-cis conformation (table 3, entry 4).  
Table 4: s-cis:s-trans ratio for the amide bonds of 20 and 21. 
20 21 
Entry Amide Bond 
s-cis:s-trans s-cis:s-trans 
1 N-terminal 1:2 1:2 
2 Central 1:6 1:15 
Measurements at 80 mM concentration in DMF-d7, 295K. 
Looking at each amide bond separately, the influence of the configuration at C(4) and of 
the C-terminal residue becomes apparent (table 4). For the conformation around the 
N-terminal amide bond, no difference between the diastereoisomers is found (table 4, 
entry 1). This is in accordance with the results presented in chapter 2.3.2, which 
indicated that 4-azidoproline derivatives with a C-terminal amide show the same 
s-cis:s-trans ratio, regardless of the configuration at C(4). The conformation around the 
central amide bond, however, shows a dependence on the configuration at C(4) (table 4, 
entry 2). While (4S)-derivative 20 shows a 1:6 ratio of the population of the s-cis:s-trans 
conformer, (4R)-derivative 21 shows a 1:15 ratio. Thus, 21 shows a 2.5-fold higher 
preference for the s-trans conformation than 20. This is in accordance with the findings 
described in chapter 2.3.1, which indicated that acetyl-(4R)-azidoproline methyl ester 15 
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has a 2- to 3-fold higher preference for the s-trans conformation than its diastereoisomer 
14. 
2.4 Conformational analysis 
To understand the basis of the higher preference for the s-trans conformation in 
N-α-acetyl-(4R)-azidoproline methyl ester 15 compared to its diastereoisomer 14, the 
conformations of the diastereoisomers were further analyzed by interpretation of the 
3J(H-H) coupling constants, as well as by COSY, TOCSY and NOESY experiments in 
various solvents.  
The pyrrolidine ring of proline can occupy a variety of conformations, which are in fast 
equilibrium with each other.[52] For the analysis of the 4-azidoproline derivatives, two 
main conformations are of importance: An endo-conformation, shown in scheme 8 on 
the top, and an exo-conformation shown on the bottom. For reasons of clarity, scheme 8 
shows idealized depictions of only one of each of the many endo- and 
exo-conformations. 
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Scheme 8: Possible conformations of the pyrrolidine ring system in azidoprolines and Newman 
projections of these conformations (idealized). 
The endo-conformation results in a pseudo-axial position of the azido-substituent in the 
case of acetyl-(4S)-azidoproline derivatives such as 14, whereas for 
acetyl-(4R)-azidoproline derivatives, such as 15, the azido-substituent is in a 
pseudo-equatorial position. Conversely, in a exo-conformation, the azide in 14 is in a 
pseudo-equatorial position, while in 15 it is in a pseudo-equatorial position. The 
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Newman projections in scheme 8 show, how the dihedral angles of these two 
conformations differ. The magnitude of the vicinal proton coupling constant, 3J(H,H), is 
dependent on the dihedral angle between the protons. This dependency can be fitted by 
the Karplus curve,[53] which enables conclusions about the dihedral angles based upon 
the magnitude of 3J(H,H) to be drawn. The Karplus curve is described by the following 
equation: 
CBAJ HH +Θ+Θ= coscos2,3  
In this equation Θ is the dihedral angle between the vicinal protons and the factors A, B 
and C are parameters used to fit the curve to specific types of molecules.[54] In the 
following discussion, the parameters used are: A = 9.5, B = -1, C = 1.4. These 
parameters were developed for cyclotriproline.[55] 
2.4.1 Conformational analysis of the pyrrolidine ring of 14 
Table 5: 3JH,H Coupling constants of N-α-acetyl-(4S)-azidoproline methyl ester 14.  
entry 3J(H,H) D2O DMF-d7 CD3OD CDCl3 
  s-trans s-cis s-trans s-cis s-trans s-cis s-trans s-cis 
1 Hα-Hβ 9.6 7.2 9.1 9.0 9.2 8.5 8.9 6.1 
2 Hα-Hβ' 2.5 3.1 4.2 1.5 3.7 1.5 4.3 4.1 
3 Hβ-Hγ 5.2 nda 6.0 5.2 5.7 4.8 nda nda 
4 Hβ'-Hγ 2.4 nda 4.7 3.0 3.8 1.6 4.4 nda 
5 Hγ-Hδ 5.3 5.3 6.1 5.4 5.9 5.5 6.1 nda 
6 Hγ-Hδ' 1.6 <1 4.0 1.5 3.5 <1 4.2 1.3 
7 Hβ'-Hδ'b 1.5 nda <1 <1 0.7 1.6 nda nda 
All measurements were performed at 80 mM concentration at 295K. a) "nd" coupling constants could not 
be determined due to signal overlap; b) 4J "W" coupling indicating the pseudo-equatorial protons at C(β) 
and C(δ). 
Table 5 shows the vicinal coupling constants of 14 in various solvents. For the analysis 
of conformation of the pyrrolidine ring, three coupling constants are of particular 
interest, the Hα-Hβ' coupling, the Hβ'-Hγ coupling and the Hγ-Hδ' coupling (table 5, 
entries 2, 4 and 6, respectively). From the magnitude of these couplings, and the 
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dihedral angles associated with them by the Karplus curve,[53,55] the conformation of the 
pyrrolidine ring was determined. 
Based on the Karplus curve and the parameters used, coupling constants close to 1.4 Hz 
are indicative of dihedral angles close to 90°. For the s-cis conformer, the vicinal 
coupling constants found for the Hα-Hβ' coupling, the Hβ'-Hγ coupling and the Hγ-Hδ' 
coupling (table 5, entries 2, 4 and 6, respectively) are almost all smaller than 3 Hz, in 
most cases even smaller than 1.5 Hz. This indicates that the dihedral angles of these 
protons are close to 90°. It is clear from the Newman projections in scheme 8 that these 
dihedral angles are in good agreement with the endo-conformation. 
The somewhat larger values found for these coupling constants in the s-trans conformer 
indicate that the pyrrolidine ring is more flexible and that a higher population of the 
exo-conformation, with the azido-substituent in the pseudo-equatorial position, is 
present. This leads to an averaging of these coupling constants, however, the magnitude 
of the coupling constants found show that the weight of this equilibrium is largely on 
the side of the endo-conformation. This is further supported by the 4J(H,H) "W" coupling 
found between Hβ' and Hδ' (table 5, entry 7), which indicates that these protons occupy 
the pseudo-equatorial positions. Thus, for both the s-cis and the s-trans conformation, 
the pyrrolidine ring of N-α-acetyl-(4S)-azidoproline methyl ester 14 favors the endo-
conformation. This leads to the azido-group being in the pseudo-axial position.  
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2.4.2 Conformational analysis of the pyrrolidine ring of 15 
Table 6: 3JH,H Coupling constants of N-α-acetyl-(4R)-azidoproline methyl ester 15. 
entry 3J(H,H) D2O DMF-d7 CD3OD CDCl3 
  s-trans s-cis s-trans s-cis s-trans s-cis s-trans s-cis 
1 Hα-Hβ 8.0 8.6 8.2 7.5 8.2 8.5 8.2 8.3 
2 Hα-Hβ' 8.3 nda 7.1 6.7 7.5 6.0 6.4 5.8 
3 Hβ-Hγ' 3.3 4.7 4.4 nda 4.1 5.0 5.0 5.1 
4 Hβ'-Hγ' 5.3 nda 5.6 nda 5.5 5.9 6.1 6.1 
5 Hγ'-Hδ 2.3 nda 3.5 nda 3.2 1.5 3.8 4.8 
6 Hγ'-Hδ' 5.9 5.5 5.4 5.7 5.2 5.7 5.6 5.8 
7 Hβ-Hδb 1.5 nda 1.2 nda 1.4 1.4 1.0 1.2 
a) "nd" coupling constants could not be determined due to signal overlap, b) 4J "W" coupling indicating 
the pseudo-equatorial protons at C(β) and C(δ). 
Analogously to the (4S)-diastereoisomer 14, the coupling constants of the 
(4R)-diastereoisomer 15 were analyzed. At the first glance, the coupling constants 
observed for 15 differ significantly from the ones observed for 14 and are not in 
agreement with an endo-conformation. The Hα-Hβ' coupling constant found (table 6, 
entry 2) is much larger than in the case of 14, while the Hγ'-Hδ coupling constant (table 
6, entry 5) is much smaller than in the case of 14. The Hγ'-Hδ coupling constant is in the 
range of 1.5-4 Hz, indicating an angle close to 60 and 90°. Furthermore, the 4J(H,H) "W" 
coupling found between Hβ and Hδ (table 6, entry 7), indicates that now these protons 
occupy the pseudo-equatorial positions. The coupling constants found match the 
dihedral angles predicted for an exo-conformation, as shown in scheme 8. The pseudo-
equatorial positions of Hβ and Hδ further support this analysis. Thus, the pyrrolidine ring 
of 15 is in an exo-conformation, with the azido-group in the pseudo-axial position. 
It is intriguing that in both diastereoisomers the azide occupies the pseudo-axial 
position. This suggests that the conformation of the pyrrolidine ring is determined by 
the azido-substituent. In both diastereoisomers, the main conformers show a gauche 
arrangement between the azide and the amide. This suggests that the conformation of 
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the pyrrolidine ring is controlled by a gauche interaction of the azido-group analogous 
to the known gauche effect found for fluoride.[56] 
2.5 Further studies using crystal structure analysis, 
IR-spectroscopy and ab initio calculations 
The studies in the previous chapters have revealed a higher preference for the s-trans 
conformation of the N-terminal peptide bond of (4R)-azidoproline methyl ester 
derivatives (see chapters 2.3.1 and 2.3.3). Thus far, no indications why this preference 
exits have been found. Therefore, further studies to understand this preference were 
undertaken. 
2.5.1 X-Ray analysis 
Single crystals of 15, suitable for X-ray diffraction were obtained by crystallization 
from acetone. Unfortunately, 14 is an oil, which could not be crystallized.  
  
Figure12: X-ray structure of N-α-acetyl-(4R)-azidoproline methyl ester 15. 
15 crystallized in a monoclinic system with four molecules per unit cell, with two 
different conformations. Figure 12 on the left, shows the s-trans Cγ-exo-conformation 
found in the crystal structure. This conformation is in good agreement with the 
conformations suggested by the anaylsis of the NMR-spectroscopical data (see chapter 
2.4.2). The second structure found (figure 12, right) shows a twisted s-cis 
Cγ-endo-conformation, which is not in agreement with the analysis of the NMR spectra 
(see chapter 2.4.2). Probably this conformation is stabilized by interactions in the crystal 
lattice and thus does not represent an overall favorable conformation. 
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The analysis of the crystal structure reveals an element of the conformation which could 
not be analyzed by the NMR studies presented in the previous chapters: The orientation 
of the methyl ester. Its orientation is such that the oxygen of the acetyl group is at an 
angle of 98° and at a distance of 2.8 Å to the carbonyl carbon of the methyl ester (figure 
13). This angle is close to the ideal 103° angle of the Bürgi-Dunitz-trajectory,[57] upon 
which a nucleophile attacks a carbonyl.  
 
Figure 13: Bürgi-Dunitz-trajectory of the acetyl oxygen on the carbonyl group (X-ray structure). 
The orientation of the methyl ester relative to the acetyl oxygen suggests a possible 
explanation for the higher s-trans preference of acetyl-(4R)-azidoproline methyl ester 
15. The s-trans conformation might be stabilized by an interaction of the non-bonding 
electrons of the acetyl group with the π*-orbital of the carbonyl bond of the methyl 
ester. Both the angle of 98° and the distance of 2.8 Å, which is well within the 
van-der-Waals distances, support this hypothesis. The existence of such an interaction is 
further supported by a slight pyramidalization of the carbonyl of the methyl ester, which 
is bent 3.7° out of its optimal plane. A similar observation was made in 4-fluroprolines, 
and has been referred to as an "n-π*" interaction.[58,59]  
This hypothesis is furthermore supported by the results presented in the previous 
chapters. It was shown that the higher preference for the s-trans conformation is 
observed in N-α-acetyl-(4R)-azidoproline methyl ester 15, but not in its amide 
derivatives 17 and 19 (see chapters 2.3.1 and 2.3.2, respectively). This is in agreement 
with the hypothesis of an "n-π*"-interaction between the acetyl group and the carbonyl 
carbon. The non-bonding electrons of the oxygen of the acetyl group may be seen as a 
nucleophile, the carbonyl carbon is the electrophile; it is interacting with the 
electrophilic carbonyl carbon. In the case of the amide derivatives 17 and 19, the 
eletrophilicity of the carbonyl carbon is greatly reduced due to the mesomeric 
2.8 Å 
98° 
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stabilization from the nitrogen of the amide, which makes the nucleophilic interaction 
less favorable. The carbonyl carbon of the methyl ester is more electrophilic and thus, 
the nucleophilic interaction may take place.[60]  
2.5.2 IR studies 
To further test the hypothesis that an interaction between the oxygen of the acetyl group 
and the carbonyl group of the methyl ester, stabilizes the s-trans conformation in 
(4R)-azidoproline derivatives, the vibrational stretching frequency of the ester carbonyl 
was determined by FT-IR spectroscopy in solution. The vibrational stretching frequency 
of carbonyl bonds is indicative of the bond length and bond order. A lower wave 
number corresponds to a lower bond order and longer bond length. An electron 
donation into the π*-orbital, as suggested by the "n-π*-interaction, should lead to a 
weakening of the double bond, the single bond character should be increased, which 
should lead to a lowering of the bond order, which should reflected in a shorter wave 
number.  
Table 7: Vibrational stretching frequencies of the ester carbonyl group of 14 and 15. 
Entry Compound CHCl3 [cm-1] Dioxane [cm-1] 
1 Ac-[Pro(4R)N3]-OCH3 15 1745.3 1747.9 
2 Ac-[Pro(4S)N3]-OCH3 14 1749.0 1752.0 
All measurements were performed at 100 mM concentration in a NaCl cell. 
In chloroform the carbonyl stretching band of the (4R)-configured acetylated 
azidoproline methyl ester 15 is 4.7 cm-1 shorter (table 7, entry 1) than the carbonyl 
stretching band of the (4S)-configured diastereoisomer 14 (table 7, entry 2). In dioxane, 
the difference is 4.1 cm-1.  
Table 8: Vibrational stretching frequencies of the ester carbonyl group of 20 and 21. 
Entry Compound CHCl3 [cm-1] 
1 Ac-[Pro(4R)N3]2-OCH3 21 1744.9 
2 Ac-[Pro(4S)N3]2-OCH3 20 1748.1 
All measurements were performed at 100 mM concentration in a NaCl cell. 
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Similarly, FT-IR spectroscopy of the acetylated dipeptides 20 and 21 in solution show 
that the vibrational stretching frequency of the ester carbonyl of Ac-[Pro(4R)N3]2-OCH3 
21 (table 8, entry 1) is 3.2 cm-1 shorter than that of the diastereomeric acetylated 
dipeptides 20 (table 8, entry 2). 
The shifts of the vibrational stretching frequencies of the diastereomeric methyl ester 
derivatives 14 and 15 and 20 and 21 support the hypothesis, that in the (4R)-configured 
methyl esters, the s-trans conformation is stabilized by an "n-π*"-interaction. 
2.5.3 Ab Initio Calculations 
The analysis of the data obtained by NMR spectroscopy, X-Ray diffraction and FT-IR 
spectroscopy suggests that the conformation of the pyrrolidine ring systems of the 
4-azidoproline derivatives is governed by a gauche effect of the azide with the 
N-terminal amide, and that the s-trans conformation of the methyl ester derivatives of 
(4R)-azidoproline is stabilized by an "n-π*"-interaction between the non-bonding 
electrons of the oxygen of the acetyl group with the carbonyl carbon of the methyl ester. 
To further investigate the gauche effect found and to gain insight into why the 
(4S)-azidoproline methyl ester derivatives do not stabilize the s-trans conformation, ab 
initio calculations were performed in collaboration.[61] Conformational searches with 
Spartan'02[62] were performed using molecular mechanic calculations with the force 
field MMFF (Merck Molecular Force Field). The structures of the conformers were 
optimized at the B3LYP/6-31G** level using the ab inito program QChem.[63] 
RI-MP2/TZVP energetics were computed with Turbomole.[64] These calculations are 
models for the gas phase and do not take solvent effects into account. 
The preference for a gauche conformation over an eclipsed or anti conformation of 
1,2-difluoroethane has been termed the gauche effect.[56] In 1,2-difluroethane, the 
gauche effect has been studied intensively in computational studies[65] and by 
spectroscopy.[66] The gauche effect has also been observed in amide derivatives, such as 
N-(2-fluoroethyl)benzamide derivatives, where it has been observed in the solid 
state.[67] Thus, as a benchmark for the accuracy of the ab intio calculations and to see if 
the azide gauche effect found in the pyrrolidine systems is also present in 
conformationally less restricted molecules, disubstituted ethane derivatives were 
initially studied by ab initio calculations. 
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Table 9: Energy differences between the anti and the gauche conformation, calculated for ethane 
derivatives. 
∆E = Eanti-Egauche [kcal mol-1] 
Entry Compound R = F R = N3 
1 R R  0.9 1.3 
2 R
N
H
O
H  
1.4 1.3 
3 R N
O  
1.7 3.3 
For each ethane derivative the energy of the two conformations, anti and gauche was 
calculated. Table 9 lists the difference between the energies calculated; positive values 
indicate a preference for the gauche conformation. The energy difference calculated for 
1,2-difluoroethane (table 9, entry 1) of 0.9 kcal mol-1 is in good agreement with the 
experimental value of 0.8 kcal mol-1.[66a] Thus, it can be assumed that the methods used 
are able to detect a gauche effect, not only in 1,2-difluoroethane, but also in other 
compounds. It is intriguing that the azidoethane derivatives all show an equal or higher 
preference for the gauche conformation than the fluoroethane derivatives (table 9, 
entries 1-3). 
After these basic studies, the energy difference between the pseudo-axial (gauche) and 
the pseudo-equatorial (anti) conformation of the substituent in the 4-position of 
azidoproline and fluoroproline was studied (table 10).  
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Table 10: Energy differences between the gauche and the anti conformation calculated for acetylated 
4-azido- and 4-fluoroproline methyl ester. 
∆E = Eanti-Egauche [kcal mol-1] 
Entry Configuration Conformation Ac[Pro(4N3)]OCH3 Ac[Pro(4F)]OCH3 
1 (4R) s-trans 0.7 0.5 
2 (4R) s-cis 1.8 1.5 
3 (4S) s-trans 0.8 0.7 
4 (4S) s-cis 3.2 3.0 
Table 10 lists the calculated energy differences between the anti and the gauche 
conformations of 4-azidoproline methyl ester and 4-fluoroproline methyl ester, positive 
values indicate a gauche preference. The ab initio calculations suggest a preference for 
the gauche conformation in all diastereoisomers of both 4-azidoproline and 
4-fluoroproline. In the s-cis conformers this preference is more pronounced than in the 
s-trans conformers. This finding is in agreement with the analysis of the NMR data as 
discussed in chapter 2.4 and the crystal structure analysis discussed in chapter 2.5.1. 
Furthermore, the energy difference between the s-trans and the s-cis conformers was 
calculated for both azido- as well as fluoroproline (table 11). 
Table 11: Energy difference between s-trans and s-cis conformations calculated for acetylated 4-azido- 
and 4-fluoroproline methyl ester. 
∆E = Es-trans-Es-cis [kcal mol-1] 
Entry Configuration Conformation Ac[Pro(4N3)]OCH3 Ac[Pro(4F)]OCH3 
1 (4R) gauche -1.6 -1.6 
2 (4R) anti -2.7 -2.6 
3 (4S) gauche 0.1 0.02 
4 (4S) anti -2.4 -2.2 
In general, the calculations show, in accordance with the data obtained by NMR (see 
chapter 2.3.1), a preference for the s-trans conformer (indicated by negative values in 
table 11). The acetylated (4S)-azidoproline methyl ester in the gauche conformation, as 
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well as the acetylated (4S)-fluoroproline methyl ester in the gauche conformation (table 
11, entry 3) shows no preference for the s-trans or the s-cis conformation.  
To judge, why acetylated (4S)-azidoproline methyl ester 14, does not seem to stabilize 
the s-trans conformation as much as acetylated (4R)-azidoproline methyl ester 15 does, 
a comparison of the lowest energy conformations was made (figure 14). The 
conformation calculated for 15 is very similar to the conformation found in the solid 
state by X-ray diffraction. Likewise, the conformation calculated for 14 is in good 
agreement with the conformation derived from the analysis of the NMR data. 
              
Figure 14: Conformations calculated for Ac[Pro(4S)N3]OCH3 14 (left) and Ac[Pro(4R)N3-OCH3 15 
(right). 
Figure 14 shows the lowest energy conformations found for the two diastereoisomers, 
14 and 15. In the conformation calculated for the (4R)-diastereoisomer 15 the angle of 
the oxygen of the acetyl group and the carbonyl group of the ester is close to 103° and 
the distance between the acetyl-oxygen and the carbonyl-carbon is calculated to be  
2.9 Å. This is in complete agreement with the conformation found in the solid state and 
the proposed "n-π*-interaction. The conformation of the diastereoisomer 14 shows an 
angle of 142° between the acetyl oxygen and the carbonyl group of the ester and the 
distance between the oxygen of the acetyl group and the carbon of the carbonyl group is 
calculated to be 3.4 Å. Thus, in the case of the (4S)-diastereoisomer, both the distance 
as well as the angle between the atoms involved, do not meet the requirements for an 
"n-π*" interaction. Therefore, a stabilization of the s-trans conformation by such an 
interaction is not feasible. This may explain why the (4R)-configured azidoproline 
3.4Å 
142° 
2.9Å 
101° 
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methyl ester derivatives show a higher pereference for the s-trans conformation than the 
(4S)-configured derivatives.  
2.6 Kinetic studies using 2D EXSY NMR 
The studies described so far, have all dealt with the thermodynamic stability of the 
different conformations of the diastereoisomers. To measure the kinetics of the 
interconversion between the conformers, two-dimensional EXSY NMR was performed.  
EXSY NMR is a variant of NOESY NMR, making use of the fact that conformers, 
which are in chemical exchange on a millisecond time scale, have two distinct sets of 
signals. Cross-peaks with opposite phase to the regular NOE cross-peaks between the 
signals corresponding to the exchanging protons are observed. These peaks arise 
because the conformers interchange during the course of the measurement, and a 
proton, which at the beginning of the experiment is in one conformation, will be in 
another conformation at the end of the experiment. The value of the sum of the rate 
constants kct and ktc, k can be determined by the following equation: [68] 
1
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tm is the mixing time of the EXSY experiment, I refers to the integrated intensity of the 
peak; the indices A and B refer to diagonal peaks of the s-cis and the s-trans conformer 
when they are equal and to cross peaks when they are different. X is the molar fraction 
of the conformers indicated in the index and k is equal to the sum of the isomerization 
rates kct and ktc. From knowledge of k and the equilibrium constant K, which was 
determined by peak integration in the 1H-NMR spectrum, the rates kct and ktc were 
calculated. 
EXSY experiments were performed with 14 and 15 in DMF-d7. By measuring a series 
of experiments at different mixing times and temperatures, sets of k values were 
generated from which sets of kct and ktc values were determined.  
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Table 12: Isomerization rates and equilibrium constants of the s-cis:s-trans equilibrium of 14 and 15.a 
 Ac[Pro(4S)N3]OCH3 14 Ac[Pro(4R)N3]OCH3 15 
T [K] kct [s-1] ktc [s-1] K[b] kct [s-1] ktc [s-1] K[b] 
285.4 0.035 0.021 1.70 0.031 0.0075 4.11 
298 0.14 0.07 1.7 0.11 0.028 3.81 
303 0.30 0.16 1.68 n.d.[c] n.d.[c] n.d.[c] 
308 0.44 0.18 1.70 0.36 0.10 3.58 
313 n.d.[c] n.d.[c] n.d.[c] 0.64 0.18 3.47 
325.3 3.5 2.1 1.70 2.6 0.83 3.10 
336.4 9.2 5.7 1.70 7.2 2.4 2.96 
348.5 28.5 16.5 1.68 21.1 7.1 2.87 
a) All measurements were performed at 80mM concentration; b) as found by integration of the signals in 
the 1H-NMR; c) " n.d." not determined. 
The studies revealed that the rate of isomerization from the s-cis to the s-trans 
conformation (table 12, kct) is equally fast in both diastereoisomers, while the 
isomerization from s-trans to s-cis (table 12, ktc) is significantly faster in the 
(4S)-derivative 14. Thus, the higher population of the s-trans conformation in 
(4R)-configured azidoproline is not due to a faster isomerization from the s-cis to the 
s-trans conformer, but due to a slower isomerization from the s-trans to the s-cis 
conformer. 
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Figure 15: Eyring plots of the rate constants for the isomerization of the acetylated proline derivatives: 
14 cis-to-trans (empty circles), 15 cis-to-trans (full circles), 14 trans-to-cis (empty diamonds), 
15 trans-to-cis (full diamonds). 
The activation enthalpy and entropy of the conversions from the s-cis to the s-trans 
conformation of the diastereomeric azidoproline derivatives were determined by 
analysis of the rate constants in Eyring plots (figure 15). The Eyring equation is defined 
as follows: 
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Where kB is the Boltzmann-constant, h is the Planck constant and R is the ideal gas 
constant. In the Eyring plot the natural logarithm of the rate constants per temperature is 
plotted against the reciprocal temperature. From the slopes of the lines defined by the 
data points the activation enthalpy of the conversion was determined. The axis intercept 
of the y-axis was used to calculate the activation entropy.  
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Table 13: Activation enthalpies and entropies of the s-cis to s-trans and s-trans to s-cis isomerization.a 
Ac[Pro(4S)N3]OCH3 14 Ac[Pro(4R)N3]OCH3 15 
Isomerization 
∆H  
[kcal mol-1] 
∆S  
[cal mol-1K-1] 
∆H  
[kcal mol-1] 
∆S  
[cal mol-1K-1] 
s-cis to s-trans 20.5 ± 0.5 6.6 ± 2.6 20.2 ± 0.5 5.2 ± 2.8 
s-trans to s-cis 20.6 ± 0.5 5.9 ± 2.6 21.4 ± 0.5 6.5 ± 2.8 
a) Extracted from Eyring plots, errors were determined by least square fit analysis. 
The analysis of the activation enthalpies and activation entropies extracted from the 
Eyring plots (table 13) shows that for both Ac[Pro(4S)N3]OCH3 14 and 
Ac[Pro(4R)N3]OCH3 15 the isomerization barrier is of enthalpic and not of entropic 
nature. Furthermore, for 14 the activation enthalpy (table 13, ∆H ) is equal for both the 
trans-to-cis and cis-to-trans isomerization. For 15 the trans-to-cis isomerization has a 
slightly higher activation energy than the cis-to-trans isomerization.  
 
Figure 16: Van't Hoff plot for Ac[Pro(4S)N3]OCH3 14 (emptry circles) and Ac[Pro(4R)N3]OCH3 15 (full 
circles). 
Finally, the temperature dependence of the equilibrium constant K was determined. 
Figure 16 shows the van't Hoff plot of Ac[Pro(4S)N3]OCH3 14 and 
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Ac[Pro(4R)N3]OCH3 15. The s-trans:s-cis equilibrium of 15 shows a slight dependence 
on temperature, approaching a 1:1 s-cis:s-trans ratio with increasing temperature (figure 
16). Interestingly, the s-trans:s-cis equilibrium of 14 is independent of the temperature. 
 
2.7 Summary 
In conclusion, by analysis of a variety of acetylated 4-azidoproline derivatives using 
NMR spectroscopy, X-ray diffraction, FT-IR spectroscopy and ab initio calculations, it 
was shown that a gauche effect between the azido-group in the 4-position and the amide 
function dominates the conformation of acetylated azidoproline derivatives. This azide 
gauche effect was confirmed by ab initio calculations of 1,2 disubstituted ethanes and 
of 4-azidoproline derivatives. Furthermore, the s-cis:s-trans ratio of a variety of 
diastereomeric 4-azidoproline derivatives was determined and a higher preference for 
the s-trans conformation in (4R)-azidoproline methyl ester derivatives was found. By 
analysis of the conformation in the solid state, FT-IR measurements and ab inito 
calculations, it was shown that the reason for the preference is likely to be an 
"n-π*"-interaction between the oxygen of the N-terminal amide with the carbonyl 
carbon of the methyl ester. The kinetics of the interconversion between the s-cis and the 
s-trans conformation of the disastereomeric acetylated 4-azidoproline methyl esters 
were studied by EXSY NMR. These studies demonstrate that the isomerization from 
s-cis to s-trans is equally fast in both diastereoisomers, while the isomerization from 
s-trans to s-cis was slower in the case of the (4R)-configured acetylated azidoproline 
methyl ester. 
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3 The Cyclotriproline Scaffold 
3.1 Background 
Previous studies demonstrated that diketopiperazine-based two-armed receptors with 
tripeptides as recognition elements (scheme 9, top) are able to bind peptides with high 
affinity and sequence selectivity in organic and aqueous media.[50,51,69,70] A scaffold 
which allows for the attachment of three recognition elements, can be expected to lead 
to receptors with even higher binding affinities since the possible number of interactions 
with the guest molecules is increased. We therefore envisaged extending the 
diketopiperazine scaffold by another proline unit to a cyclotriproline derived scaffold. 
(scheme 9, bottom). 
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Scheme 9: Schematic drawings of the diketopiperazine receptor class (top) and the two possible 
diastereomeric cyclotriproline receptors (bottom); RE= recognition element. 
Since the configuration at C(4) had proven to have a significant effect on the 
conformation and binding properties of the diketopiperazine receptors,[51] 
conformational searches were initially performed, using MacroModel 7.1[71,72] (figure 
17). As the recognition elements will be attached by amide linkages (as in the case of 
the diketopiperazine based receptors), the two diastereoisomers 
cyclotri[(4S)-acetamidoproline] 33 and cyclotri[(4R)-acetamidoproline] 32 were used as 
minimal receptor models in these computational studies. The calculations used the 
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OPLS-AA[73] force field and the GB/SA[74] model for chloroform. Searching was 
performed using the MCMM method in blocks of 20'000 steps.  
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Figure 17: Lowest energy conformations of cyclotri[(4R)-acetamidoproline] (top) and 
   cyclotri[(4S)-acetamidoproline] (bottom) as calculated by MacroModel 7.1.  
In the case of the (4R)-derivative 32 (figure 17, top), the conformational searches 
yielded a flat, star-like arrangement of the acetamides, which occupy the 
pseudo-equatorial positions of the pyrrolidine rings as the lowest energy conformation. 
For a possible receptor, this arrangement is not favorable, as the recognition elements 
would be pointing away from each other. In the lowest energy conformation found for 
the (4S)-derivative 33 (figure 17, bottom), however, the acetamides occupy the pseudo-
axial positions of the pyrrolidine rings, leading to a bowl-shaped structure. This creates 
a pocket which should be favorable for the enclosure of guest molecules.[51] 
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Figure 18: Cyclotri[(4S)-azidoproline] 34. 
Taking these considerations into account, cyclotri[(4S)-azidoproline] 34 (figure 18) was 
envisioned as a precursor for synthetic tripodal receptors. 
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3.2 Synthesis of the Cyclotriproline Scaffold 
The logical precursor to cyclotri[(4S)-azidoproline] 34 is the linear tripeptide. The 
synthesis of linear tri[(4S)-azidoproline] 36 (scheme 10) commences from 
Boc[Pro(4S)N3]2OCH3 31.  
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a) i) NaOH (2 eq), H2O, THF, MeOH, r.t., 2h; ii) 30 (1.5 eq), HATU (3 eq), iPr2NEt (9 eq), DMF, r.t., 
95%; e) i) NaOH (4 eq), H2O, THF, MeOH, r.t., 2h; ii) 4M HCl in dioxane, r.t., 30 min., 90%. 
Scheme 10: Synthesis of tri[(4S)-azidoproline] 36. 
The methyl ester 31 was saponified and the resulting acid coupled with the 
hydrochloride salt 30, using HATU as the coupling reagent. The resulting methyl ester 
35 was again saponified and the Boc-group was removed using 4M HCl in dioxane, 
which afforded the hydrochloride salt 36.  
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a) pyridine, 1-4 days, 65°C; b) coupling reagent, iPr2NEt (9 eq), DMF, 2h, r.t. 
Scheme 11: Cyclization methods tested for cyclotriproline. 
3.2  Synthesis of the Cyclotriproline Scaffold 39 
For the cyclization, a series of different reaction conditions were examined. Initially, the 
cyclization was attempted following the classical approach as used by Rothe (scheme 
11, top);[75] an active ester derivative of the tripeptide was added to pyridine over the 
course of 16 hours by syringe-pump to a final peptide concentration of 1mM. Pyridine 
acted both as solvent and base. After 96 hours reaction time at 65°C, 40% of the 
cyclized product was isolated (table 14, entries 1 and 2). 
Table 14: Cyclization conditions and yields for cyclotri[(4S)-azidoproline] 34. 
Entry Reactant Conditions Yield 
1 37 pyridine, 1d, 65°Ca 11 % 
2 38 pyridine, 4d, 65°C 40 % 
3 36 TBTUb, 2h, r.t., 31 % 
4 36 PyBop, 2h, r.t. 38 % 
5 36 HATU, 2h, r.t. 74 % 
a: Final peptide concentration: 1mM; b: Final peptide concentration: 8 mM. 
To optimize the reaction conditions, the cyclization was attempted by addition of a 
DMF solution of the hydrochloride salt 36 by syringe-pump during 1 hour to a solution 
of DMF with different coupling reagents and Hünig's base to a final peptide 
concentration of 8 mM (scheme 11, bottom). Under these conditions, the reaction was 
complete after 2 hours at room temperature. For TBTU and PyBOP, the yields were 
comparable to the yield obtained by addition of the C-terminally activated peptide to 
pyridine (table 14, entries 3 and 4). Using HATU as coupling reagent, the product was 
isolated in 74% yield even on a 1g scale. 
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a) coupling reagent (3 eq), iPr2NEt (9 eq), DMF, 2h, r.t. 
Scheme 12: Cyclization of tri[(4R)-azidoproline] 39. 
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The diastereomeric tripeptide, tri[(4R)-azidoproline] 39 was synthesized analogously to 
36 and was also tested in cyclization experiments (scheme 12).  
Table 15: Cyclization conditions and yield for the cyclization of 16. 
Entry Conditions Yield 
1 TBTU, 2h, r.t.a < 10 % 
2 PyBop, 2h, r.t.a < 15 % 
3 HATU, 2h, r.t.a < 15 % 
a: Final peptide concentration: 8 mM. 
Under identical conditions the cyclization yields of tri[(4R)-azidoproline] 39 were 
significantly lower than the yields obtained with the diastereomeric tripeptide 36 (table 
15). Using HATU and PyBOP as coupling reagents (table 15, entries 2 and 3) less than 
15% yield was obtained, using TBTU (table 15, entry 1) the yield was even less than 
10%. The low yields obtained for the cyclization of 39 can be explained by the higher 
preference for the s-trans conformation in (4R)-azidoproline derivatives as described in 
the previous chapter. 
3.3 Global reduction of the azides to amines followed by acetylation 
To allow for the attachment of recognition elements to the cyclotriproline scaffold, the 
azides were reduced to amines. The reduction of the azides was achieved both through 
hydrogenation with palladium on activated charcoal as a heterogeneous catalyst, as well 
as by Staudinger reduction, using trimethyl phosphine and water (scheme 13).  
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a) Pd/C, H2, MeOH/THF (3/1), r.t, 1h, quant.; b) P(CH3)3 in THF (2M), H2O, 15 min., r.t., quant.; c) 
Ac2O, NEt3, CH2Cl2, 90%. 
Scheme 13: Reduction of the azide groups and acetylation of cyclotri [(4S)-azidoproline]34.  
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Acetylation of the amines using acetic anhydride in the presence of triethylamine, 
yielded cyclotri[(4S)-acetamido proline] 33, which served as a minimal receptor model 
for conformational analysis.  
 
3.4 Structural analysis of cyclotri[(4S)-azidoproline] 34 
Single crystals suitable for X-ray diffraction of cyclotri[(4S)-azidoproline] 34 were 
obtained by crystallization from chloroform.  
 
 
Figure 19: X-ray structure of cyclotri [(4S)-azidoproline] 34, ORTEP view (right) and capped stick view 
(left). 
By X-ray diffraction, the unit cell was found to be orthorhombic, with four molecules 
per cell. Figure 19 shows the structure of cyclotri[(4S)-azidoproline] 34 in the 
crystalline state. The C3-symmetry is only slightly distorted; one of the three pyrrolidine 
rings of the azidoprolines is in a perfect N-exo-conformation, the second shows a 
slightly distorted N-exo-conformation and the third is in a Cδ-endo-conformation. The 
azides are in a neutral position, which cannot be determined as pseudo-equatorial or 
pseudo-axial.  
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Table 16: Comparison of coupling constants found for 34 and coupling constants calculated. 
Entry Protons 
Coupling constant 
founda [Hz ± 0.5] 
Coupling constant expected 
for N-exob [Hz ± 0.5] 
Coupling constant exp. for 
distorted N-exob [Hz ± 0.5] 
1 Hα-Hβ 8.2 8.7 8.9 
2 Hα-Hβ' 2.1 1.8 2.0 
3 Hβ-Hγ 10.0 9.9 9.8 
4 Hβ'-Hγ 5.2 4.1 5.7 
5 Hγ-Hδ 8.1 9.0 8.0 
6 Hγ-Hδ' 8.1 7.8 9.4 
a) Coupling constants as determined by 1H-NMR spectroscopy in CDCl3 at 295K. b) N-exo and distorted 
N-exo conformation as found in the crystal structure. 
To analyze whether the conformation found in the crystalline state also occurs in 
solution, NMR studies were performed. The NMR spectrum of 
cyclotri[(4S)-azidoproline] in CDCl3 shows a six-spin system for the pyrrolidine ring 
protons, indicating that on the average time scale of the NMR measurement, a 
C3-symmetric conformation is present. The vicinal coupling constants of 34 in 
chloroform were compared to values expected for the torsion angles found in the crystal 
structure. These expected vicinal coupling constants were calculated based on the 
Karplus equation (see chapter 2.4),[53,54] using parameters developed for 
cyclotriproline[55] (table 16). The vicinal coupling constants found for the Hα-Hβ, 
Hα-Hβ', and the Hβ-Hγ coupling (table 16, entries 1-3) match the expected values within 
the margin of error. The values found for the Hβ'-Hγ, the Hγ-Hδ and the Hγ-Hδ' coupling 
lie between the values expected for the N-exo-conformation and the distorted N-
exo-conformation found in the crystal structure (table 16, entries 4-6). This indicates 
that the conformation in solution is likely to be a dynamic equilibrium between different 
forms of the N-exo-conformation found in the crystal structure. 
In conclusion, the conformations determined by interpretation of the vicinal coupling 
constants of the 1H-NMR in CDCl3 and the conformation found in the crystal structure 
are in agreement. Furthermore, unlike in the acetylated monomers studied in chapter 
2.4, in cyclotri[(4S)-azidoproline] 34 the azido-groups are not in the pseudo-axial 
conformation and assume an anti-conformation relative to the amide bond. This is 
probably due to the conformation of the nine-membered inner ring, which dominates the 
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conformation of the pyrrolidine rings, and thereby overrides the gauche effect observed 
for the linear 4-azidoproline derivatives (see chapters 2.4 and 2.5). 
3.5 Structural analysis of cyclotri[(4S)-acetamidoproline] 33 
Since receptors based on the cyclotriproline scaffold are designed to have amide 
linkages to the recognition elements, the conformation of the (4S)-acetamide derivative 
33 was studied as a minimal receptor fragment. As in the case of the azide-derivative 
34, the NMR spectrum of 33 in CDCl3 shows a six-spin system for the pyrrolidine ring 
protons, indicating that on the average time scale of the NMR measurement, a 
C3-symmetric conformation is present. 
Table 17: Coupling constants of cyclotri[(4S)-acetamido proline] 33. 
Entry 3J(H,H) 
Coupling Constant  
[Hz ± 0.5] 
Coupling Constant  
expected [Hz ± 0.5]a 
1 Hα-Hβ 7.4 7.6 
2 Hα-Hβ' < 1 1.4 
3 Hβ-Hγ 9.1 7.8 
4 Hβ'-Hγ < 1 1.4 
5 Hγ-Hδ 8.7 9.3 
6 Hγ-Hδ' 4.1 2.3 
7 HN-Hγ 9.5 n.d. 
a From calculating the vicinal coupling constant using the Karplus equation and the dihedral angles found 
in the MacroModel calculation described in chapter 3.1. 
The vicinal coupling constants of the acetamide derivative 33 (table 17) differ from the 
vicinal coupling constants of azide derivative 34 (see table 16), indicating a change in 
conformation. The main difference lies in the coupling constants Hα-Hβ' and especially 
Hβ'-Hγ ( table 17, entries 2 and 4), which are less than 1 Hz, corresponding to a dihedral 
angle between these protons of approximately 90°. The two 90° torsion angles between 
Hα and Hβ', and Hβ' and Hγ can only be realized in a conformation, in which the 
acetamide-groups are in the pseudo-axial positions. The vicinal coupling constants 
found for cyclotri[(4S)-acetamido proline] 33 are in agreement with both a 
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Cβ-exo-conformation and a Cα-endo-conformation, as these conformations differ only 
slightly in the torsion angles. 
The Cβ-exo-conformation was also found to be the lowest energy conformation of 
cyclotri[(4S)-acetamido proline] 33 in the calculations using MacroModel (see figure 
17, bottom). The coupling constants found for the Hα-Hβ' and the Hβ'-Hγ coupling are in 
good agreement with the ones expected for the lowest energy conformation by the 
Karplus[53,54] equation using parameters optimized for cyclotriproline.[55] The values 
expected for the coupling constants of Hα-Hβ, Hα-Hβ', Hβ'-Hγ and Hγ-Hδ (table 17, 
entries 1, 2, 4 and 5) match the values found by 1H-NMR within the margin of error. 
This indicates that the conformation found in the conformational searches is a good 
representation of the conformation in chloroform solution. 
The lowest energy conformation found by conformational searches suggests a possible 
explanation for the difference in conformation found between 
cyclotri[(4S)-azidoproline] 34, in which the Cγ-substituents (the azido-groups) are in 
neutral positions and the pyrrolidine ring is in a N-exo-conformation, and 
cyclotri[(4S)-acetamido proline] 33, in which the Cγ-substituents (the acetamide-groups) 
are in a pseudo-axial conformation and the pyrrolidine ring systems are in a 
Cβ-exo-conformation (figure 20).  
 
Figure 20: Lowest energy conformation of [4S-acetamidoproline] 33 as calculated by MacroModel 7.1, 
possible hydrogen bond shown in red.  
1.9Å 
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The distance (1.9Å) and orientation of the N-H bonds of the acetamide relative to the 
carbonyl groups of the cyclic backbone found in the lowest energy conformation of 
cyclotri[(4S)-acetamido proline] 33, suggest that the conformation of the pyrrolidine 
rings is stabilized by intramolecular hydrogen bonding (figure 20). This hydrogen bond 
could overrule the conformational preference induced by the nine-membered inner ring, 
leading to the conformation observed. 
To test whether these hydrogen bonds are also present in the conformation found in 
solution by NMR spectroscopy, NOE spectroscopy was performed. 
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Scheme 14: NOE contacts in cyclotri [(4S)-acetamido proline] 33, shown for one of the pyrrolidine rings. 
The arrows indicate NOE contacts, while the dashed line indicates a possible hydrogen bridge. 
Scheme 14 shows the intense NOE contacts found in 2D NOE spectroscopy of 
cyclotri[(4S)-acetamido proline] 33. NOE contacts of the N-H to the δ'- and β'-protons 
are detected, while no NOE contacts to the δ and β protons and only a weak NOE 
contact to the γ-proton is found, suggesting that rotation around the Cγ-NAc bond is 
restricted and that the N-H bond is orientated towards the inner 9-membered ring. This 
is further supported by the HN-Hγ coupling constant of 9.5 Hz (table 17, entry 7), 
indicating a trans geometry of the N-H and Cγ-Hγ bond. This leads to a conformation in 
which the N-H bond is orientated towards the carbonyl of the central, nine-membered 
ring, bringing them in a conformation, which supports the existence of a possible 
hydrogen bond. 
In this conformation, the acetamides occupy the pseudo-axial conformation, giving the 
molecule a bowl-shaped form, opening a cavity in between the recognition elements in 
which host molecules can interact with the receptor. Such a conformation has been 
favorable in the case of the diketopiperazine receptors developed previously.[50,51,69,70] 
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3.6 Summary 
Based on computational models of the two diastereoisomers of cyclotri[4-acetamido 
proline], cyclotri[(4S)-azidoproline] 34 was envisioned as the precursor to tripodal 
molecular receptors. 34 was synthesized and its conformation was analyzed using NMR 
spectroscopy. Cyclotri[(4S)-acetamidoproline] 33 was synthesized as a minimal 
receptor fragment to analyze the conformation of the pyrrolidine rings in a receptor. The 
conformational analysis suggests that a tripodal molecular scaffold based on 
cyclotri[(4S)-aminoproline] should be a good molecular template for synthetic 
receptors.  
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4 Binding Studies of a Cyclotriproline-Based Peptide 
Receptor 
 
4.1 Synthesis of cyclotriproline based peptide receptors 
Based on the finding that the conformation of the (4S)-amide-substituted cyclotriproline 
(see chapter 3.5) is likely to be suitable as a scaffold for a tripodal receptor, a model 
receptor was synthesized. Previous studies in the Wennemers group showed that 
diketopiperazine receptors functionalized with acid-rich peptides as recognition 
elements recognize arginine-rich sequences selectively in aqueous buffers.[70] Thus, an 
analogous three-armed receptor was designed. Dye-marked tyrosine[50] was chosen as 
the first amino acid of the tripeptidic recognition element, as it allows for visual 
detection of binding in on-bead combinatorial binding assays. Aspartates were chosen 
as second and third amino acid in the recognition elements, in order to introduce acidic 
functional groups.  
The cyclotriproline based peptide receptors were synthesized by coupling the Disperse 
Red-marked Boc-Tyr(DR)-OH[50] to the primary amines of cyclotri[(4S)-aminoproline] 
41. HATU in DMF with Hünig's base was used as coupling reagent in the first coupling 
step. After removal of the Boc-protecting group by treatment with 4M HCl in dioxane, 
the resulting hydrochloride salt was coupled in CH2Cl2 with Fmoc-Asp(tBu)-OH using 
EDC as coupling reagent to yield the dipeptide modified cyclotriproline 43. After 
Fmoc-deprotection using diethylamine, another Fmoc-Asp(tBu)-OH was coupled as the 
last amino acid of the receptor "arms".  
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a) Boc-Tyr(DR)-OH (4.5 eq), HATU (6 eq), iPr2NEt (18 eq), DMF, 2h, r.t., 60%; b) i) 4 M HCl in 
dioxane, 0 min., r.t.; ii) Fmoc-Asp(tBu)-OH (6 eq), EDC (6.3 eq), iPr2NEt (7 eq), 2h, r.t, 91%; c) HNEt2 
(60 eq), CH2Cl2/AcCN 2/1, 1h, r.t.; ii) Fmoc-Asp(tBu)-OH (6 eq), EDC (6.3 eq), CH2Cl2, 1h, r.t., 62%; 
d) i) HNEt2 (60 eq), CH2Cl2/AcCN 2/1, 1h, r.t.; ii) AcOH (100 eq), HCTU (300 eq), iPr2NEt (900 eq), 
DMF, 2h, r.t., 50%; e) 50% TFA in CH2Cl2, 1h, r.t., 90%. 
Scheme 15: Synthesis of the cyclotriproline based peptide receptors. 
After removal of the Fmoc-group, the N-termini of the peptides were acetylated to yield 
45. The side-chain protecting groups were removed using 50% TFA in CH2Cl2 to yield 
the final receptor 46 (scheme 15).  
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4.2 Combinatorial Screenings 
To test the binding properties of the cyclotriproline based peptide receptor 46, 
combinatorial on-bead assays in aqueous buffer against an encoded [76,77] split-and-
mix[78,79] library of tripeptides[80] were performed. In the library, 31 D- and L-amino 
acids were used in each position of the combinatorially varied tripeptide, leading to a 
maximum of 29'791 different tripeptide sequences. To allow for further cleavage studies 
the tripeptide was flanked by nitrotyrosine on the N-terminus and by an anthranilic acid 
functionalized lysine on the C-terminus (scheme 16). 
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Scheme 16: General structure of the combinatorial tripeptide library used. 
Each amino acid in the library was encoded with a set of "tags", which may later be 
used to identify the tripeptide sequence.[76,77] The "tags" of the library consist of 
chloro-phenol ethers of long chain diols, which can be detected in their silylated form 
using a gas chromatograph with an electron capture detector (ECD). The tags have 
different retention times, due to different chain lengths and substitution patterns. The 
amino acids are encoded in a binary fashion, with each tag representing one digit. Five 
tags together code for one position of the library. 
For the screenings, 10 mM Tris·HCl buffer at pH 7.2, 10 mM NaHCO3 buffer at pH 8.5 
and 10 mM NaOH at pH 12 were used. Since the side chain carboxylic acid of aspartate 
has a pKa of 3.9, screenings at acidic pH were not performed, as the carboxylates of the 
aspartates in the receptor arms would become at least partially protonated. The 
interaction between the receptor and the peptide is assumed to be at least in part based 
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upon electrostatic interactions, thus protonated, and therefore neutral, aspartate residues 
would not be favorable. 
After 24 hours at room temperature, inspection of the beads under a visual light 
microscope showed that in 10 mM Tris·HCl buffer at pH 7.2 none of the beads had 
picked up the red color of the receptor 46 (figure 21a). In 10 mM NaHCO3 buffer at pH 
8.5 some of the beads had picked up the red color (figure 21b) of the dye-marked 
receptor 46, indicating a binding interaction. The screening in 10 mM NaOH at pH 12.0 
(figure 21c) also showed red beads. 
Figure 21: Screenings of the dye-marked receptor 46 in different buffers; a) 10 mM Tris·HCl buffer at pH 
7.2 (left); b) 10 mM NaHCO3 buffer at pH 8.5 (middle); c) 10 mM NaOH at pH 12.0 (right). 
Comparing the results of the screenings at pH 8.5 and 12.0 under the microscope, it was 
found that for the screenings at pH 8.5 most of the beads remained colorless (the slight 
yellow coloring of the beads is inherent of the library at basic pH), some show a slight 
hue of orange and a few are slightly red (approximately 1 in 150). At pH 12, again most 
beads remained colorless, but here, the beads that did pick up the color of the receptor 
46, are dark red (approximately 1 in 150), rather than just orange. This indicates that the 
binding of receptor 46 at pH 12 is probably more specific than at pH 8.5. 
 
To elucidate the tripeptide sequence on the beads which picked up the color of the 
receptor, several of the red beads were isolated and the "tags" of each bead were cleaved 
off separately and analyzed by ECD-GC. 
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Table 18: Percentage of L- and D-arginine in the sequences found in the screenings of 46. 
10 mM NaHCO3 buffer pH 8.5a 10 mM NaOH at pH 12.0b 
Entry Position L-Arg D-Arg Total L-Arg D-Arg Total 
1 AA1 28% 49% 77% 18% 15% 33% 
2 AA2 23% 40% 63% 33% 39% 72% 
3 AA3 28% 35% 63% 42% 36% 78% 
a) a total of 43 sequences were analyzed; b) a total of 33 sequences were analyzed. 
Previous results had shown that receptors based on the diketopiperazine scaffold with 
tripeptidic recognition elements bind arginine-rich sequences in basic aqueous buffer.[70] 
Based on these results it was expected that the cyclotriproline based receptor would also 
bind arginine-rich sequences, which it does indeed (table 18). Furthermore, depending 
on the buffer and pH used, slight differences in selectivity were found. In 10 mM NaOH 
at pH 12.0, receptor 46 binds mainly peptides with sequences containing an arginine as 
the second and third amino acid, indiscriminate of stereochemistry (table 18, entries 2 
and 3). In 10 mM NaHCO3 buffer pH at 8.5 on the other hand, receptor 46 binds 
peptides with sequences containing almost equal frequencies of arginine in all three 
positions (table 18, entries 1-3). Intriguingly, for positions 1 and 2 an almost 1:2 ratio 
between L-and D-arginine (table 18, entries 1 and 2) is found. 
Table 19: Distribution of sequences containing at least two arginines. 
Entry Sequencea NaHCO3 buffer pH 8.5b NaOH pH 12.0c 
1 Arg-Arg-X 12 % 51 %d 
2 X-Arg-Arg 28 % 18 % 
3 Arg-X-Arg 37 % 21 % 
4 Arg-Arg-Arg 12 % 3 % 
  Total: 89%e Total: 94%e 
a) Arg stands for both L- and D-arginine, X stands for any other amino acid; b) a total of 43 sequences 
were analyzed; c) a total of 33 sequences were analyzed; d) 70% of the residues found in the X position 
were hydrophobic amino acids; e) the remaining sequences contained one arginine residue.  
Most sequences found for receptor 46, both in 10 mM NaHCO3 buffer at pH 8.5 and in 
10 mM NaOH at pH 12.0, contain at least two arginine residues (table 19, totals). 
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Nonetheless, the pH influences the distribution of sequences found. In 10 mM NaHCO3 
buffer at pH 8.5 receptor 46 selects for peptides with sequences with an Arg-X-Arg 
motif, in which the two arginines are flanking another, random, amino acid (table 19, 
entry 3). Likewise, with nearly equal selectivity, sequences with an X-Arg-Arg motif 
were found, in which a random amino acid is followed by two arginines (table 19, entry 
2). In contrast, in 10 mM NaOH at pH 12.0, receptor 46 shows a preference for peptides 
with an Arg-Arg-X motif, in which two arginines are followed by a random amino acid. 
This sequence was not favored in 10 mM NaHCO3 buffer at pH 8.5 (table 19, entry 1). 
While the overall selectivity for sequences with at least two arginines was equal for 
both screening conditions (table 19, totals), the selectivity for a triple arginine sequence 
was slightly higher in 10 mM NaHCO3 buffer at pH 8.5 (table 19, entry 4). The 
differences in selectivity found for the different buffers and pH, indicate that small 
changes can influence the binding.  
In summary, the combinatorial on-bead screenings show that receptor 46 binds to 
arginine-rich sequences, both in 10 mM NaOH at pH 12.0, as well as in 10 mM 
NaHCO3 buffer at pH 8.5. In 10 mM NaOH at pH 12.0, the screenings indicate that 
receptor 46 has a preference for sequences containing an Arg-Arg-X motif, where X is a 
random amino acid. In 10 mM NaHCO3 buffer at pH 8.5, receptor 46 displays 
selectivity for arginines in each of the three positions, and also shows binding to a triple 
arginine sequence. 
 
4.3 Determination of Binding Affinities by Isothermal Titration 
Calorimetry 
To analyze the binding affinity of receptor 46 to a specific target sequence, isothermal 
titration calorimetry (ITC) was performed. During ITC the enthalpy ∆H is measured 
while the ligand is titrated to the receptor. The enthalpy released per injection changes 
over the course of the titration, as the receptor molecules become saturated with 
peptidic guest molecules. From the change in enthalpy per injection in dependence of 
the molar ratio of receptor to ligand, the stoichiometry of the complex, the enthalpy ∆H, 
the binding constant K, and from it the free energy, ∆G, of the binding is determined. 
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The combinatorial screening indicated that receptor 46 is able to bind to arginine-rich 
sequences (see chapter 4.1). In 10mM NaHCO3-buffer at pH 8.5, receptor 46 binds to 
sequences with at least two arginine residues, as well as to triple arginine. To get an 
estimate of the binding energy, the peptide Ac-Arg-Arg-Arg-NH-propyl was used as 
guest molecule. Previous studies with diketopiperazine-based receptors have shown 
that, even though other sequences were also found in the screening, the binding affinity 
was highest with a triple arginine sequence.[81] An N-acetylated peptide with a 
propylamide C-terminus was used since the tripeptides in the library used are part of 
longer peptides, and therefore do not bear a free N- or C-terminus either. 
Two ITC measurements were performed, with receptor concentrations of 150 µM and 
175 µM, respectively, at 25° C in 10mM NaHCO3 buffer at pH 8.0. A solution of the 
target peptide in 10mM NaHCO3 buffer at pH 8.0 was titrated to the receptor in aliquots 
of 5 µL. A total of 59 injections were made, at five minute intervals. As the peptide was 
titrated to the receptor, the ratio of receptor to peptide changed from 8:1 to 1:8 in the 
measurement performed with a 150 µM receptor concentration, and from 10:1 to 1:6.5 
in the measurement performed with 175 µM receptor concentration.  
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Figure 22: ITC titration curves and fits of the curves of the change of ∆H per injection. Left 
 measurement 1, right measurement 2. 
In an ITC measurement, the area underneath the curve recorded is equal to the ∆H per 
injection. For the interpretation of the data measured, ∆H per injection is plotted against 
the molar ratio of receptor to ligand (figure 22). The titration curve for ∆H recorded for 
the titration of the ligand to a buffer solution without receptor is subtracted, eliminating 
the heat of dilution of the peptide. The data is fitted using a method of least squares, in 
which the complex stoichiometry, ∆H of the complex formation and the binding 
constant are varied.[82]  
The best fit for the data recorded showed a 2:1 receptor:peptide complex. The 
mathematical model used assumes a receptor with two independent binding sites, which 
bind one substrate per binding site. The fit therefore provides two different binding 
constants for the two different binding sites as well as ∆H and T∆S values for each 
complexation step.[82] 
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Table 20: Thermodynamic data determined for the binding of 46 with the peptide 
Ac-Arg-Arg-Arg-NH-propyl by ITC measurements. 
Entry Thermodynamic Parametera Value foundb 
1 ∆G1 [kcal/mol] -6.0 ± 0.1 
2 ∆G2 [kcal/mol] -4.9 ± 0.1 
3 ∆H1 [kcal/mol] -2.2 ± 0.1 
4 ∆H2 [kcal/mol] -2.9 ± 0.1 
5 T∆S1 [kcal/mol] 3.9 ± 0.1 
6 T∆S2 [kcal/mol] 2.0 ± 0.1 
a) The subscripts of the values denote the two different binding events, b) averaged values of two 
measurements, using 150µM and 175µM receptor solutions.  
The two measurements are in close agreement, showing that the binding is a 
reproducible event. Table 20 shows the averaged values for the thermodynamic 
parameters determined. The binding energy for the first binding (table 20, entry 1), ∆G 
is averaged to be -6.0±0.1 kcal mol-1 (Ka = 25500±500 M-1). The second binding energy 
(table 20, entry 2) is averaged to be -4.9±0.1 kcal mol-1 (Ka = 4300±500 M-1). The other 
thermodynamic data indicate, that the binding is favored both enthalpically (table 20, 
entries 3 and 4) and entropically (table 20, entries 5 and 6). As the binding constants are 
relatively close to each other, the least square fit is equally good when the chronological 
order of binding is reversed, thus the first binding might be the second in time and vice 
versa. 
4.4 Summary 
The dye–marked tripodal receptor 46 was screened in combinatorial on-bead assays at 
different pH against an encoded split-and-mix library of approximately 29'000 different 
tripeptides. The acid-rich receptor 46 shows selectivity for arginine-rich sequences. ITC 
measurements show that receptor 46 binds peptides in a 2:1 peptide:receptor 
stoichiometry, with binding affinities, ∆G, averaging at -6.0±0.1 kcal mol-1 and -4.9±0.1 
kcal mol-1. 
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5 Conclusions and Outlook 
 
This thesis presents studies on the influence of the azido-substituent on the 
conformation of 4-azidoproline. An azide gauche effect was observed in several 
diastereomeric 4-azidoproline derivatives by conformational analysis using a 
combination of NMR-spectroscopy, X-ray diffraction, FT-IR-spectroscopy and ab initio 
calculations. This gauche effect dominates the conformation of both, (4R)- and 
(4S)-configured azidoproline derivatives. As a result, the pyrrolidine ring adopts a 
Cγ-endo-conformation in the case of the (4S)-configured derivatives and a 
Cγ-exo-conformation in the case of the (4R)-configured derivatives. Furthermore, in the 
comparison of the s-cis/s-trans equilibrium of acetylated 4-azidoproline derivatives, the 
(4R)-azidoproline methyl ester derivatives show a higher preference for the s-trans 
conformation than the (4S)-diastereoisomers. This s-trans preference of the 
(4R)-derivatives was rationalized by a stabilization of the s-trans conformation by an 
"n-π*"-interaction of the non-bonding electrons of the acetyl oxygen with the carbonyl 
carbon of the methyl ester. The kinetics of this equilibrium were studied and the 
individual rate constants and activation enthalpy and entropy were determined by EXSY 
NMR. 
(4S)-azidoproline was then employed in the synthesis of a tripodal molecular scaffold 
for synthetic receptors. A model receptor with tripeptidic, acid-rich recognition 
elements was prepared and showed selective binding properties to arginine-rich 
peptides in combinatorial on-bead screenings. Isothermal titration calorimetry (ITC) 
studies revealed binding affinities, ∆G, in the range of -5 to -6 kcal mol-1 for a 2:1 
peptide:receptor complex with the tripeptide Arg-Arg-Arg in aqueous media.  
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The azide gauche effect in general and the effect of the 4-azido substituent on the 
conformation of proline in particular, can be applied to the design of conformationally 
defined molecules. For instance, the stability of secondary structure elements, such as 
the polyproline II (ppII) helix, which is found in collagen, is dependent on the 
conformation of the amide bond. All amide bonds in a ppII helix are in the s-trans 
conformation. Thus, introduction of (4R)-azidoproline should increase the stability of 
the ppII helix due to its higher preference for the s-trans conformation. Furthermore, 
4-azidoproline can not only be used as a structure directing element, but also allows for 
further modifications, for example, by reaction with alkynes in a [3+2] cycloaddition 
(also referred to as "Click Chemistry"). Polyproline II helices containing 4-azidoproline 
are therefore going to be applied in the design of new materials and as inhibitors of 
helical peptide binding proteins. 
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6 Experimental Section 
 
6.1 List of abbreviations 
 
AA amino acid 
Ac  acetyl 
Ac2O acetic anhydride 
AcOH acetic acid 
Ala alanine 
anh. anhydrous 
aq. aqueous 
Arg arginine 
Asn aspargine 
Asp aspartic acid 
Bn benzyl  
Boc tert-butyloxycarbonyl 
Boc2O tert-butyloxycarbonyl anhydride 
CAM ceric ammonium molybdate  
DEPBT 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one  
DIAD diisopropylazodicarboxylate 
DIPEA N,N-diisopropylethylamine 
DMAP N,N-dimethylamino pyridine 
DMF N,N-dimethylformamide 
DMSO dimethylsulfoxide 
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DNA deoxyribonucleic acid 
DR disperse Red 
EC-GC electron capture gas chromatography 
EDC 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
eq equivalent 
Et3N triethylamine 
EXSY Exchange spectroscopy 
Fmoc 9-fluorenylmethoxycarbonyl 
Gln glutamine 
Glu glutamic acid 
Gly glycine 
h hour(s) 
HATU O-(7-azabenzotriazol-1-yl)1,1,3,3-tetramethyluronium  
 hexafluorophosphate 
HCTU 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethlyuronium 
 hexafluorophosphate 
His histidine 
HOBt N-hydroxybenzotriazole 
Leu leucine 
Lys lysine 
min minute(s) 
MsCl methansulfonylchloride 
NaN3 Sodium azide 
NOE nuclear overhauser enhancement 
NOESY nuclear overhauser enhancement spectroscopy 
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Pbf 2,4,6,7-Pentamethyldihydrobenzofurane-5-sulfanyl 
PEG polyethylene glycol 
Pfp pentafluorophenol 
Phe phenylalanine 
Pmc 2,2,5,5,7,8-pentamethylchroman-6-sulfonyl 
PPh3 triphenylphosphine 
Pro proline 
quant. quantitative 
r.t. room temperature 
sat. saturated 
Ser serine 
sol. solution 
TBTU 2-(1H-Benzotriazole-1-yl)-1,1,3,4-tetramethyluronium  
tetrafluoroborate 
TFA trifluoro acetic acid 
THF tetrahydrofuran 
Thr threonine 
TLC thin layer chromatography 
UDP uridine 5'-diphosphate 
Val valine 
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6.2 General Methods 
Materials and reagents were of the highest commercially available grade and used 
without further purification. Reactions were monitored by thin layer chromatography 
using Merck silica gel 60 F254 plates. Compounds were visualized by UV, ceric 
ammonium molybdate (CAM) and ninhydrin. Flash chromatographies were performed 
using Merck silica gel 60, particle size 40 - 63 µm. Gel filtrations were performed on 
Sephadex LH20 resin purchased from Sigma. 1H and 13C NMR spectra were recorded 
on a Varian Gemini 300, a Bruker DPX 400 or a Bruker DPX 500 spectrometer. 
Chemical shifts are reported in ppm using CHCl3 and TMS as a reference. Infrared 
spectra were obtained on a Perkin-Elmer 1600 series; peaks are reported in cm-1. 
Finnigan MAT LCQ and TSQ 700 instruments were used for electrospray ionization 
(ESI) mass spectrometry. 
 
EXSY-NMR Spectroscopy. Experiments were performed on a Bruker DMX 600 
instrument (600.13 MHz) using a 5 mm inverse broadband probe equipped with a 
shielded z-gradient. Samples of Ac[Pro(4S)-N3]OMe and Ac[Pro(4R)-N3]OMe were 
prepared in DMF-d7 (99.5 % D) and were both 80 mM. Experiments were performed in 
the temperature range from 288 K to 345 K. Temperature calibrations were carried out 
using a glycerol standard and were reproducible within ±0.5 K. For each temperature 
setting, a one-dimensional 1H-NMR spectrum was recorded with a recovery delay of  
10 s, to allow for complete relaxation. The trans:cis ratio K was obtained from these 
spectra by simple peak integration. EXSY spectra were recorded using a standard pulse 
scheme[83,84]: 90x-t1-90x-tmixing/2-grad(z)-180x-grad(-z)-tmixing/2-90x-aquisition. 
2048 data points in the direct and 512 data points in the indirect dimension were 
collected using a TPPI phase cycle resulting in acquisition times of 170 ms and 85 ms 
respectively. After zero-filling in the indirect dimension to 1024 data points, shifted 
squared sine bell window functions were applied in both dimensions prior to Fourier 
transformation. For a given temperature at least five EXSY spectra were recorded with 
different mixing times in a range from 10 ms to 4s to obtain cross peak intensities that 
were smaller than the diagonal peak intensities for all temperatures. Linear baseline 
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corrections were carried out in both dimensions and peak volumes were determined 
manually. At least two resonances (O-CO-CH3 and Hα or Hδ') were analyzed 
independently for each compound in order to minimize experimental errors. 
Kinetics. Rate constants were calculated from peak volumes using the following 
equation:[68]  
1
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Where r is defined as follows: 
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tm is the mixing time of the EXSY experiment, I refers to the integrated intensity of the 
peak; the indices A and B refer to diagonal peaks of the s-cis and the s-trans conformer 
when they are equal and to cross peaks when they are different. X is the molar fraction 
of the conformers indicated in the index and k is equal to the sum of the isomerization 
rates kAB and kBA. 
For each temperature the ten (or fifteen) independent values for k were averaged and 
kAB and kBA were obtained thereof using the mole fraction obtained from the 
one-dimensional 1H-NMR spectra. Thermodynamic parameters and their standard 
deviations were then obtained by linear least-squares fitting of kAB, kBA and K to the 
Eyring and Van't Hoff equation. 
 
Isothemal Titration Calorimetry. Titrations were performed at 25°C using a Microcal 
VP-ITC titration microcalorimeter. Sample solutions were prepared using Milli-Q 
water. Titrations of Ac-Arg-Arg-Arg-NHPr were performed by adding aliquots of a  
5 mM peptide solution to a 0.2 mM receptor solution. The titrations were analyzed 
using a least squares curve-fitting procedure (Origin® implemented with the 
calorimetric setup provided by Microcal). 
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6.3 General Procedures: 
 
6.3.1 General procedure for the saponification of a methyl-ester (2 mmol scale):  
The methyl ester was dissolved in a 1:1 mixture of THF and MeOH (20 mL) and a 
solution of NaOH (1.5 eq) in water (2 mL) was added. The reaction mixture was stirred 
for 2 h at room temperature and was then carefully acidified to pH 4 using 1M HCl. 
CH2Cl2 (100 mL) and water (20 mL) were added, and the mixture was extracted once 
with additional 1M HCl (20 mL). The aqueous layer was extracted with CH2Cl2  
(2×50 mL), the organic layers were washed with brine and dried over Na2SO4. Filtration 
and evaporation of the solvent at reduced pressure yielded the acid that was used 
without further purification, unless otherwise stated. 
 
6.3.2 General procedure for the formation of a Pentafluorophenyl ester  
(2 mmol scale): 
Pentafluorophenol (Pfp-OH) (1.05 eq) and 1-(3-Dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (EDC) (1.5 eq) were added to the solution of the 
carboxylic acid in CH2Cl2 (5 mL). The reaction mixture was stirred for 1 h, then 
extracted with CH2Cl2 (100 mL) and 0.5M HCl (50 mL). The aqueous layer was 
extracted with CH2Cl2 (2×50 mL) and the combined organic phases were dried over 
Na2SO4. Filtration and removal of all volatiles afforded the Pfp-ester. 
 
6.3.3 General procedure for Boc-deprotection (2 mmol scale):  
The Boc-protected amine was dissolved in 4M HCl in dioxane (5 mL) and stirred at 
room temperature for 1 hour. After removal of all volatiles at reduced pressure, the 
residue was triturated with Et2O (3×10 mL) providing the HCl-salt. 
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6.3.4 General procedure for Fmoc-deprotection (2 mmol scale) 
The Fmoc-protected amine was dissolved in CH2Cl2/AcCN 3/1 (4 mL). Diethylamine 
(200 eq) was added and the reaction mixture was stirred at room temperature for 1 hour. 
After removal of all volatiles at reduced pressure, the residue was triturated with 
pentanes (3×10 mL) providing the free amine. 
 
6.3.5 General procedure for the coupling of a Pfp-ester with a HCl-salt  
(2 mmol scale): 
The Pfp-ester (1.1 eq) was added to a solution of the HCl-salt (1 eq) in CH2Cl2 (2 mL) 
and Hünig's base (2.5 eq). After stirring over night, the reaction mixture was extracted 
with CH2Cl2 (100 mL) and 0.5M HCl (50 mL). The aqueous layer was extracted with 
CH2Cl2 (2×50 mL) and the combined organic layers were dried over Na2SO4. Filtration 
and removal of all volatiles at reduced pressure yielded the crude product. 
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6.4 Synthesis of the acetylated 4-azidoproline derivatives 
6.4.1 Synthesis of the monomeric methyl ester derivatives. 
6.4.1.1 Boc-(4S)-azidoproline methyl ester 24 
 
NBoc
N3 CO2Me
 
Boc-hydroxyproline methyl ester (16.28 g, 66.36 mmol) was cooled to 0°C in dry 
CH2Cl2 (30 mL). Triethylamine (11.08 mL, 79.63 mmol) and methanesulfonylchloride 
(6.2 mL, 79.63 mmol) were added. After 30 minutes, the reaction mixture was extracted 
with sat. NaHCO3 solution (30 mL). The aqueous phase was washed twice with CH2Cl2 
(15 mL). The combined organic layers were dried and the solvent was removed in 
vacuo. The residual oil was dissolved in dry DMF (50 mL). Sodium azide (21.57 g, 
331.8 mmol) was added and the suspension was stirred for 3 hours at 80°C. The DMF 
was removed in vacuo and the residual slurry was taken up in diethyl ether (50 mL). 
Remaining sodium azide was filtered off and the filtrate was extracted with sat. 
NaHCO3 solution (50 mL). The aqueous phase was washed with diethyl ether  
(3×30 mL). The combined organic layers were dried and the solvent was removed in 
vacuo to yield the desired Boc-(4S)-azidoproline methyl ester 24 (17.93 g, 66.36 mmol, 
quant.).  
 
The NMR-spectra show a mixture of major and minor signals or two conformers. 
1H NMR (400 MHz, CDCl3, 25°C): δ = 4.38 (dd, J = 8.8 Hz, 3.5 Hz, 1H; Hα minor), 4.27 (dd, J = 8.6 
Hz, 4.0 Hz, 1H; Hα major), 4.11 (m, 1H; Hγ major + minor), 3.71 (s, 3H; OCH3 major+ minor), 3.66 (m, 
1H; Hδ major + minor), 3.43 (m, 1H; Hδ major + minor), 2.43 (m, 1H; Hβ major + minor) 2.12 (dt, J= 
13.5, 4.4 1H; Hβ major + minor), 1.43 (s, 9H; tbu minor), 1.37 (s, 9H; tbu major). 
 
13C NMR (100 MHz, CDCl3, 22°C): δ (major) = 172.1, 153.3, 80.4, 58.1, 57.6, 52.1, 35.9, 28.1. 
13C NMR (100 MHz, CDCl3, 22°C): δ (minor) = 171.8, 153.8, 80.4, 59.1, 57.2, 51.1, 35.0, 28.2. 
 
ESI-MS: m/z: calculated for C11H18N4O4 [M+Na]+ 293; found 293 (100%). 
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6.4.1.2 Acetyl-(4S)-azidoproline methyl ester 14 
 
NAc
N3 CO2Me
 
Boc-[Pro-(4S)-N3]OCH3 24 (340 mg, 1.258 mmol) was Boc-deprotected following the 
general procedure. The crude product was reacted with acetic anhydride (238 µL,  
2.517 mmol) and triethylamine (524 µL, 3.774 mmol) in dry CH2Cl2 (2 mL). The 
reaction was monitored by T.L.C., after completion, 1M HCl (1 mL) was added and the 
mixture was extracted twice with ethyl acetate (25 mL). The combined organic layers 
were dried and the solvent was removed in vacuo. After flash chromatography on silica 
gel (gradient of DCM:MeOH from 98:2 to 97:3) the acetylated methyl ester 14 (253 mg, 
1.192 mmol, 95%) was isolated as a colorless oil. 
 
1H NMR (500 MHz, DMF-d7, 25°C): δ (s-trans) = 4,53 (m, 1H; Hγ) , 4,49 (dd, J = 9.2, 4.3, 1H; Hα), 
3,97 (dd, J = 11, 6.1, 1H; Hδ), 3,54 (dd, J = 11, 3.9, 1H; Hδ'), 2,62 (ddd, J = 13.5, 9.2, 6, 1H; Hβ), 2,03 
(dt, J = 13.5, 4.3, 1H; Hβ');  
1H NMR (500 MHz, DMF-d7, 25°C): δ (s-cis) = 4,84 (dd, J = 9.05, 1.5, 1H; Hα), 4,53 ppm (m, 1H; Hγ), 
3,69 (dd, J = 13, 5.5, 1H; Hδ), 3,41 (dt, J = 13, 1.5, 1H; Hδ), 2,62 (m, J = 9.05, 5.2, 1H; Hβ), 2,38 (dddd, 
J = 13.7, 3.2, 1.5, 0.4, 1H; Hβ').  
 
13C NMR (125 MHz, DMF-d7, 25°C): δ (s-trans) = 172.3, 169.4, 57.7, 60.2, 52.3, 52.7, 34.9, 22.1. 
13C NMR (125 MHz, DMF-d7, 25°C): δ (s-cis) = 172.7, 170.1, 59.1, 59.1, 52.8, 51.7, 36.7, 22.1. 
 
ESI-MS: m/z: calculated for C8H12N4O3 [M+Na]+ 235; found 235 (100%); [2M+Na]+ 447; found 447 
(60%).  
 
Elemental analysis calculated for C8H12N4O3 (212,09): C 45,28; H 5,70; N 26,40; found: C 45.26; H 5.63; 
N 26.28.  
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6.4.1.3 Boc-(4R)-azidoproline methyl ester 26 
 
NBoc
N3 CO2Me
 
A solution of triphenylphosphine (9.5 g, 36.239 mmol, 1.8 eq) and methanesulfonic acid 
(1.57 mL, 24.160 mmol 1.2 eq) were stirred in dry toluene (20 mL). Following the 
addition of triethylamine (1.12 mL, 8.053 mmol, 0.4 eq) and boc-hydroxyproline 
methyl ester (5.232 g, 20.133 mmol, 1 eq) dissolved in dry toluene (2.5 mL), DIAD  
(7.8 mL, 40.266 mmol, 2 eq) was added drop-wise. The temperature of the reaction 
mixture was held below 35°C by cooling with an ice bath. After completion of the 
addition, the reaction mixture was heated to 70°C for 3 h. After cooling, the reaction 
mixture was poured in sat. NaHCO3 (100 mL) solution and extracted three times with 
CH2Cl2 (100 mL). The combined organic layers were dried over Na2SO4 and 
evaporated. The crude mesylate was dissolved in DMF (15 mL) and NaN3 (6.54 g, 
100.665 mmol, 5 eq) was added. The reaction mixture was stirred at 80°C for 3 h. After 
cooling, the solvent was removed at reduced pressure. The residual oil was dissolved in 
Et2O (100 mL) and poured onto sat. NaHCO3 solution (100 mL). The aqueous phase 
was extracted with Et2O (3×100 mL). The combined organic layers were dried with 
Na2SO4 and evaporated. After flash chromatography on silica gel (gradient of 
pentanes:ethyl acetate from 10:1 to 7.5:1) N-α-Boc-(4R)-azidoproline methyl ester 26 
(4.327 g, 16.009 mmol, 80%) was isolated as a colorless oil. 
 
1H and 13C NMR show a double set of peaks (≈ 1.5:1) due to the s-trans and s-cis conformers.  
1H NMR (400 MHz, CDCl3, 25°C): δ (major) = 4.31 (dd, J = 8.8 Hz, 4.4 Hz, 1H; Hα), 4.15 (m, 1H; Hγ), 
3.75 (s, 3H; OCH3), 3.7 (m, 1H; Hδ), 3.45 (m, 1H; Hδ), 2.49 (m, 1H; Hβ) 2.16 (m, 1H; Hβ), 1.41 (s, 9H; 
C(CH3)3);  
1H NMR (400 MHz, CDCl3, 25°C): δ (minor) = 4.42 (dd, J = 8.9Hz, 3.8 Hz, 1H; Hα), 4.15 (m, 1H; Hγ), 
3.75 (s, 3H; OCH3), 3.7 (m, 1H; Hδ), 3.45 (m, 1H; Hδ), 2.49 (m, 1H; Hβ) 2.16 (m, 1H; Hβ), 1.47 (s, 9H; 
C(CH3)3). 
13C NMR (100 MHz, CDCl3, 22°C): δ (major) = 172.9, 153.3, 80.6, 58.7, 57.7, 52.1, 51.2, 36.2, 28.1. 
13C NMR (100 MHz, CDCl3, 22°C): δ (minor) = 172.7, 153.9, 80.6, 59.2, 57.3, 52.3, 51.3, 35.3, 28.3. 
ESI-MS: m/z: calculated for C11H18N4O4 [M+Na]+ 293; found 293 (100%). 
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N-α-acetyl-(4R)-Azidoproline methyl ester 15 
 
NAc
N3 CO2Me
 
N-α-acetyl-(4R)-azidoproline methyl ester 15 was synthesized according to the same 
procedure as 14.  
 
1H NMR (500 MHz, DMF-d7, 25°C): δ (s-trans) = 4.53 (m, J = 9.3, 5.1, 3.9, 1H; Hγ) 4.38 (dt, J = 7.7, 
1H; Hα), 3.89 (dd, J = 11.1, 5.3, 1H; Hδ'), 3.66 (m, 1H; Hδ), 2.38 (dddd, J = 12.0, 8.2, 4.4, 1.2, 1H; Hβ), 
2.25 (dd, J = 7.1, 5.6, 1H; Hβ'). 
1H NMR (500 MHz, DMF-d7, 25°C): δ (s-cis) = 4.78 (dd, J = 8.0, 6.4, 1H; Hα), 4.43 (m, J = 9.2, 5.4, 1H; 
Hγ), 3.66 (m, 1H; Hδ), 3.56 (dd, J = 12.3, 5.7, 1H; Hδ'), 2.48 (m, 1H; Hβ'), 2.23 (dd, J= 7.1, 5.6, 1H; 
Hβ).  
 
13C NMR (125 MHz, DMF-d7, 25°C): δ (s-trans) = 172.8, 169.3, 60.7, 57.9, 53.1, 52.3, 35.3, 22.1;  
13C NMR (125 MHz, DMF-d7, 25°C): δ (s-cis) = 173.1, 169.8, 59.0, 58.9, 52.92, 51.2, 37.0, 21.6.  
 
ESI-MS: m/z: calculated for C8H12N4O3 [M+Na]+ 235; found 235 (100%); [2M+Na]+ 447; found 447 
(60%). 
 
Elemental analysis calculated for C8H12N4O3 (212,09): C 45,28; H 5,70; N 26,40; found: C 45.27; H 5.64; 
N 26.36.  
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6.4.2 Synthesis of the monomeric amide derivatives. 
6.4.2.1 Boc-(4S)-azidoproline pentafluorophenyl ester 27 
 
NBoc
N3 CO2Pfp
 
The methyl ester of Boc-(4S)-azidoproline methyl ester 24 (2.00 g, 7.40 mmol) was 
saponified with NaOH (0.44 g, 11.04 mmol) following the general procedure. The 
resulting acid was reacted with pentafluorophenol (1.43 g, 7.77 mmol) and EDC  
(2.13 g, 11.11 mmol) following the general procedure to provide the Pfp-ester 27 (2.90 
g, 6.87 mmol, 93%) as a colorless oil. 
 
1H and 13C NMR show a double set of peaks (≈ 2:1) due to the s-trans and s-cis conformers. 
1H NMR (300 MHz, CDCl3, 25°C): δ (major) = 4.70 (dd, 9.3 Hz, 2.8 Hz, 1H; Hα), 4.29 (m, 1H; Hγ), 3.76 
(m, J = 11.9, 1H; Hδ), 3.63 (dd, J = 11.8 Hz, 2.5 Hz, 1H; Hδ´), 2.68 (m, 1H; Hβ), 2.37 (m, 1H; Ηβ´), 1.46 
(s, 9H; tbu); δ (minor) = 4.76 (dd, J = 9.2 Hz, 3.2 Hz, 1H; Hα), 4.29 (m, 1H; Hγ), 3.76 (m, J = 11.9, 1H; 
Hδ), 3.54 (dd, J = 11.3 Hz, 3.0 Hz, 1H; Hδ´), 2.68 (m, 1H; Hβ), 2.37 (m, 1H; Ηβ´), 1.49 (s, 9H; tbu). 
 
13C NMR (100.5 MHz, CDCl3, 25°C): δ (major) = 168.3, 153.6, 143.5, 138.8, 81.9, 59.8, 57.7, 51.5, 36.9, 
28.5; δ (minor) = 168.0, 153.9, 143.5, 138.8, 81.6, 60.8, 57.5, 51.7, 35.8, 28.7. 
 
FT-IR (NaCl, ν/cm-1): 2980, 2118, 1798, 1713, 1518, 1260.  
 
ESI-MS: m/z: calculated for C16H15F5N4O4 [M+H]+ 423; found 423 (100%).  
Elemental analysis calculated for C16H15F5N4O4 (422.3): C 45.51, H 3.58, N 13.27; found C 45.27, H 
3.56, N 13.14. 
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6.4.2.2 Boc-(4S)-azidoproline dimethyl amide 28 
 
NBoc
N3
O
N
 
Boc-Pro[(4S)-N3]-OPfp (147 mg, 0.348 mmol) was dissolved in dry CH2Cl2 (2.5 mL). 
Dimethlyamine hydrochloride (284 mg, 3.48 mmol) and triethylamine (540 µL,  
3.83 mmol) were added and the reaction mixture was stirred at room temperature for 30 
min. The reaction mixture was diluted with CH2Cl2 (10 mL) and extracted with 1N HCl 
(10 mL). The aqueous layer was extracted twice with CH2Cl2 (10 mL). The combined 
organic layers were dried using Na2SO4. After evaporation, the residual oil was purified 
by flash chromatography on silica gel (gradient, CH2Cl2:MeOH 100:0 to 96:4) to yield 
Boc-[Pro-(4S)-N3]-N(CH3)2 (86 mg, 0.303 mmol, 87%) as a colorless oil.  
 
1H NMR (400 MHz, CDCl3, 25°C): δ (major) = 4.65 (dd, J = 8.5 Hz, 6.4 Hz, 1H; Hα), 4.04 (m, 1H; Hγ), 
3.85 (dd, J = 11.0 Hz, 7.1 Hz, 1H; Hδ), 3.42 (d, J = 11.0 Hz, 1H; Hδ), 3.05 (s, 3H; NCH3), 2.96 (s, 3H; 
NCH3), 2.53 (t, J = 7.7 Hz, 1H; Hβ), 1.89 (m, 1H; Hβ), 1.43 (s, 9H; tbu).  
 
1H NMR (400 MHz, CDCl3, 25°C): δ (minor) = 4.55 (t, J = 7.8 Hz, 1H; Hα), 4.02 (m, 1H; Hγ), 3.90 (dd, 
J = 10.7 Hz, 7.3 Hz, 1H; Hδ), 3.40 (d, J = 10.9 Hz, 1H; Hδ), 3.03 (s, 3H; NCH3), 2.72 (s, 3H; NCH3), 
2.55 (t, J = 7.9 Hz, 1H; Hβ), 1.87 (m, 1H; Hβ), 1.37 (s, 9H; tbu).  
 
13C NMR (100 MHz, CDCl3, 22°C): δ (major) = 170.9, 153.9, 80.3, 58.3, 55.0, 53.4 51.0, 36.8, 34.6, 
28.3. 
13C NMR (100 MHz, CDCl3, 22°C): δ (minor) = 171.3, 153.2, 80.2, 57.6, 55.2, 55.0, 50.4, 36.1, 35.3, 
28.2. 
 
ESI-MS: m/z: calcd for C12H21N5O3 [M+Na]+ 306; found 306 (100%). 
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6.4.2.3 Boc-(4S)-azidoproline pyrrolidine amide 29 
 
NBoc
N3
O
N
 
Boc-[Pro(4S)-N3]OPfp 27 (50 mg, 0.118 mmol) was dissolved in dry CH2Cl2 (1 mL). 
Pyrrolidine (20 µL, 0.236 mmol) was added and the reaction mixture was stirred at 
room temperature for 30 min. The reaction mixture was diluted with CH2Cl2 (10 mL) 
and extracted with 1N HCl (10 mL). The aqueous layer was extracted twice with 
CH2Cl2 (10 mL). The combined organic layers were dried using Na2SO4. Evaporation 
of the solvent yielded Boc-(4S)-azidoproline pyrrolidineamide (36 mg, 0.118 mmol, 
quant.) as a colorless solid.  
 
1H NMR (400 MHz, CDCl3, 25°C): δ = 4.32-4.49 (m, 2H; Hα), 4.01 (m, 1H), 3.37 (1H), 3.29-3-71 (m, 
5H), 2.52 (m, 1H), 1.75-2.01 (m, 5H), 1.35-1.44 (9H, tbu). 
 
The carbon spectrum shows a 1:1 mixture of signals. 
13C NMR (100 MHz, CDCl3, 22°C): δ = 169.7, 169.4, 153.9, 153.2, 80.2, 58.3, 57.6, 56.7, 56.4, 51.0, 
50.4, 46.2, 46.1, 35.2, 34.5, 28.4, 28.2, 26.3, 26.2, 24.0, 23.9. 
 
ESI-MS: m/z: calcd for C9H15N5O2 [M+Na]+ 332; found 332 (100%). 
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6.4.2.4 Acetyl-(4S)-azidoproline dimethyl amide 16 
 
NAc
N3
O
N
 
Boc-Pro[(4S)-N3]-N(CH3)2 (106 mg, 0.374 mmol) was Boc-deprotected according to 
the general procedure. The crude product was reacted with acetic anhydride (175 µL, 
1.87 mmol) and triethylamine (420 µL, 2.99 mmol) in dry CH2Cl2 (1 mL). The reaction 
was monitored by T.L.C., after completion, 1M HCl (1 mL) was added and the mixture 
was extracted twice with ethyl acetate (25 mL). The combined organic layers were dried 
and the solvent was removed in vacuo. After flash chromatography on silica gel 
(gradient of CH2Cl2:MeOH from 99:1 to 95:5) the acetylated dimethyl amide 16  
(76 mg, 0.337 mmol, 90%) was isolated as a colorless oil. 
 
1H NMR (500 MHz, DMF-d7, 22°C): δ (s-trans) = 4.38 (dd, J = 8.5 Hz, 6.6 Hz, 1H; Hα), 4.49 (ψq, J = 
14.5 Hz, 7.1 Hz, 1H; Hγ), 4.09 (dd, J = 10.4 Hz, 7.1 Hz, 1H; Hδ), 3.41 (dd, J = 10.4 Hz, 7.3 Hz, 1H; Hδ), 
3.10 (s, 3H; NCH3), 2.86 (s, 3H; NCH3), 2.74 (m, 1H; Hβ), 2.00 (s, 3H; acetyl-CH3), 1.76 (dt, J = 12.9 
Hz, 6.9 Hz, 1H; Hβ). 
1H NMR (500 MHz, DMF-d7, 22°C): δ (s-cis) = 5.05 (dd, J = 9.0 Hz, 4.3 Hz, 1H; Hα), 4.36 (m, 1H; Hγ), 
3.93 (dd, J = 12.3 Hz, 6.7 Hz, 1H; Hδ), 3.33 (dd, J = 12.3 Hz, 5.0 Hz, 1H; Hδ), 3.13 (s, 3H; NCH3), 2.93 
(s, 3H; NCH3), 2.88 (m, 1H; Hβ), 1.97 (m, 1H; Hβ), 1.80 (s, 3H; acetyl-CH3). 
 
13C NMR (125 MHz, DMF-d7, 22°C): δ (s-trans) = 171.3, 168.5, 59.3, 55.6, 52.6, 36.8, 34.5, 34.7, 22.3. 
13C NMR (125 MHz, DMF-d7, 22°C): δ (s-cis) = 171.1, 169.6, 58.1, 57.9, 51.3, 36.7, 36.6, 35.7, 21.7. 
 
ESI-MS: m/z: calcd for C9H15N5O2 [M+Na]+ 248; found 248 (100%); [2M+Na]+ 473; found 473 (80%). 
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6.4.2.5 Acetyl-(4S)-azidoproline pyrrolidine amide 18 
 
NAc
N3
O
N
 
Boc-(4S)-azidoproline pyrrolidineamide (35 mg, 0.142 mmol) was Boc-deprotected 
following the general procedure. The crude product was reacted with acetic anhydride 
(67 µL, 0.71 mmol) and polyvinylpyridine (50 mg, ~ 0.71 mmol) as solid base in dry 
CH2Cl2 (1 mL). The reaction mixture was stirred over night at room temperature. The 
polyvinylpyridine was filtered off and washed with CH2Cl2 (3×3 mL). After removal of 
the solvent, the residual oil was purified by flash chromatography on silica gel (gradient 
of CH2Cl2:MeOH from 99:1 to 95:5) to yield the acetylated pyrrolidineamide 18  
(31 mg, 0.125 mmol, 88%) as a colorless oil. 
 
1H NMR (400 MHz, DMF-d7, 25°C): δ (major) = 4.59 (t, J = 7.7 Hz, 1H; Hα), 4.37 (m, 1H; Hγ), 4.08 
(dd, J = 10.2 Hz, 7.1 Hz, 1H; Hδ), 3.67 (m, 2H; pyrrolidine), 3.48 (m, 2H; pyrrolidine), 3.39 (dd, J = 10.2 
Hz, 7.7 Hz, 1H; Hδ), 2.73 (m, 1H; Hβ), 2.00 (s, 3H; CH3), 1.93 (m, 2H; pyrrolidine), 1.81 (m, 1H; Hβ), 
1.79 (m, 2H; pyrrolidine).  
 
1H NMR (400 MHz, DMF-d7, 25°C): δ (major) = 4.83 (dd, J = 9.0 Hz, 4.7 Hz, 1H; Hα), 4.36 (m, 1H; 
Hγ), 3.94 (dd, J = 12.1 Hz, 6.8 Hz, 1H; Hδ), 3.36 (m, 2H; pyrrolidine), 3.31 (m, 1H; Hδ), 3.29 (m, 2H; 
pyrrolidine), 2.86 (ddd, J = 13.2 Hz, 9.0 Hz, 6.9 Hz, 1H; Hβ), 1.99 (m, 1H; Hβ), 1.82 (s, 3H; CH3), 1.81 
(m, 2H; pyrrolidine), 1.77 (m, 2H; pyrrolidine).  
 
13C NMR (125 MHz, CDCl3, 22°C): δ = 169.1, 168.9, 58.4, 56.2, 52.0, 46.3, 46.0, 34.0, 26.1, 24.0, 22.3. 
 
ESI-MS: m/z: calcd for C9H15N5O2 [M+Na]+ 274; found 274 (100%); [2M+Na]+ 525; found 525 (30%). 
6.4  Synthesis of the acetylated 4-azidoproline derivatives 77 
6.4.2.6 Acetyl-(4R)-azidoproline dimethyl amide 17 
 
N
O
O
N
N3
 
Acetyl-(4R)-azidoproline dimethyl amide 17 was synthesized in analogy to acetyl-(4S)-
azidoproline dimethyl amide 16. 
 
1H NMR (500 MHz, DMF-d7, 22°C): δ (s-trans) = 4.91 (dd, J = 8.3 Hz, 6.1 Hz, 1H; Hα), 4.49 (ψq, J = 
9.6 Hz, 5.5 Hz, 1H; Hγ), 3.84 (dd, J = 11.0 Hz, 5.5 Hz, 1H; Hδ), 3.64 (ddd, J = 11.0 Hz, 3.4 Hz, 1.1 Hz, 
1H; Hδ'), 3.14 (s, 3H; NCH3), 2.84 (s, 3H; NCH3), 2.36 (dddd, J = 13.1 Hz, 8.3 Hz, 4.5 Hz, 1.2 Hz, 1H; 
Hβ), 2.14 (dt, J = 13.3 Hz, 6.0 Hz, 1H; Hβ'), 2.01 (s, 3H; acetyl-CH3). 
 
1H NMR (500 MHz, DMF-d7, 22°C): δ (s-cis) = 5.12 (dd, J = 8.5 Hz, 5.86 Hz, 1H; Hα), 4.37 (m, J = 9.4 
Hz, 5.6 Hz, 3.9 Hz, 1H; Hγ), 3.68 (ddd, J = 12.3 Hz, 3.2 Hz, 1.4 Hz, 1H; Hδ), 3.55 (dd, J = 12.3Hz, 
5.5Hz, 1H; Hδ), 3.16 (s, 3H; NCH3), 2.93 (s, 3H; NCH3), 2.65 (dddd, J = 13.0 Hz, 8.5Hz, 4.4 Hz, 1.5 Hz, 
1H; Hβ), 2.42 (dt, J = 13.4 Hz, 5.9 Hz, 1H; Hβ), 1.82 (s, 3H; acetyl-CH3). 
 
13C NMR (125 MHz, DMF-d7, 22°C): δ (s-trans) = 171.5, 168.3, 60.5, 55.0, 53.1, 36.6, 34.9, 22.0. 
13C NMR (125 MHz, DMF-d7, 22°C): δ (s-cis) = 171.3, 169.16, 58.9, 56.9, 51.4, 36.5, 36.3, 35.4, 21.3. 
 
ESI-MS: m/z: calculated for C9H15N5O2 [M+Na]+ 248; found 248 (100%); [2M+Na]+ 473; found 473 
(40%). 
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6.4.2.7 Acetyl-(4S)-azidoproline pyrrolidine amide 19 
 
N
O
O
N
N3
 
Acetyl-(4S)-azidoproline pyrrolidine amide 19 was synthesized in analogy to 
acetyl-(4S)-azidoproline pyrrolidine amide 18. 
 
1H NMR (400 MHz, CDCl3, 25°C): δ = 4.69 (dd, J = 7.9 Hz, 5.8 Hz, 1H; Hα), 4.46 (m, 1H; Hγ), 3.92 (m, 
2H; 2Hδ), 3.32-3.56 (m, 4H, pyrrolidine H), 2.26 (m, 1H; Hβ), 2.16 (m, 1H; Hβ), 2.05 (s, 3H, CH3) 1.78-
2.02 (m, 4H, pyrrolidine H). 
 
13C NMR (100 MHz, CDCl3, 25°C): δ = 169.7, 169.0, 59.8, 56.2, 52.8, 46.5, 46.0, 34.7, 26.0, 24.1, 22.3. 
 
ESI-MS: m/z: calcd for C9H15N5O2 [M+Na]+ 274; found 274 (100%); [2M+Na]+ 525; found 525 (30%). 
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6.4.3 Synthesis of the dimeric methly ester derivatives 
 
6.4.3.1 (4S)-azidoproline methyl ester hydrochloride 30 
 
NH2+
CO2MeN3
Cl-  
 
Boc-[Pro-(4S)-N3]OCH3 24 (1.20 g, 4.44 mmol) was deprotected following the general 
protocol yielding the HCl-salt 30 (916 mg, 4.44 mmol, quant.).  
 
1H NMR (400 MHz, CD3OD, 25°C): δ = 4.62 (dd, J = 9.9 Hz, 4.2 Hz, 1H; Hα), 4.58 (m, 1H; Hγ), 3.52 
(dd, J = 12.5 Hz, 5.0 Hz, 1H; Hδ), 3.45 (dt, J = 12.5 Hz, 1.8 Hz, 1H; Hδ´), 2.65 (ddd, J = 14.4 Hz, 9.9 Hz, 
5.6 Hz, 1H; Hβ), 2.43 (dddd, J = 14.4 Hz, 4.2 Hz, 2.5 Hz, 1.6 Hz, 1H; Ηβ´). 
 
13C NMR (100.5 MHz, CD3OD, 25°C): δ = 169, 59.6, 58.6, 53.2, 51.1, 34.2. 
 
ESI-MS: m/z: calculated for C6H10N4O2 [M+H]+ 171; found 171 (100%). 
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6.4.3.2 Boc-di-(4S)-azidoproline methyl ester 31 
 
CO2CH3
N3
N
O
N3
N
Boc
 
The Pfp-ester 27 (2.06 g, 4.88 mmol) and the HCl-salt 30 (916 mg, 4.44 mmol) were 
coupled following the general procedure. The crude product was purified by flash 
chromatography on silica gel (CH2Cl2:MeOH 100:1) yielding the dipeptide 31 (1.64 g, 
4.02 mmol, 90%) as a colorless oil.  
 
1H and 13C NMR show a double set of peaks (≈ 2:1) due to the s-trans and s-cis conformers.  
1H NMR (500 MHz, CDCl3, 25°C): δ (major) = 4.73 (dd, J = 4.6 Hz, 4.4 Hz, 1H; Hα), 4.48 (dd, J = 8.4 
Hz, 6.8 Hz, 1H; Hα), 4.28 (m, 1H; Hγ), 4.07 (m, 2H; Hγ, Hδ), 3.82 (dd, J = 7.1 Hz, 10.9 Hz, 1H; Hδ), 
3.72 (s, 3H; CH3), 3.47 (ddd, J = 14.7 Hz, 4.3 Hz, 10.4 Hz, 1H; Hδ), 3.38 (dd, J = 10.9 Hz; 7.1 Hz 1H; 
Hδ), 2.61 (dt, J =13 Hz, 7.8 Hz, 1H; Hβ), 2.47 (ddd, J = 6 Hz, 9 Hz, 14.7 Hz, 1H; Hβ), 2.17 (dt, 13.5 Hz, 
4.4 Hz, 1H; Hβ), 2.09 (m, 1H; Hβ), 1.4 (s, 3H; CH3). 
 
1H NMR (500 MHz, CDCl3, 25°C): δ (minor) = 4.69 (dd, J = 8.9 Hz, 4.4 Hz, 1H), 4.37 (t, J = 7.6), 4.27 
(m, 1H), 4.08 (m, 1H), 3.88 (m, 2H), 3.74 (s, 3H), 3.48 (m, 1H), 3.39 (m, 1H), 2.61 (m, 1H), 2.41 (m, 
1H), 2.22 (m, 1H), 2.07 (m, 1H), 1.37 (s, 3H). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ (major) = 171.2, 170.3, 154.2, 80.7, 59.7, 58.5, 57.5, 56.3, 52.7, 
51.4, 51.1, 34.4, 34.1, 28.5. 
 
13C NMR (125 MHz, CDCl3, 25°C): δ (minor) = 170.9, 170.4, 154.2, 80.6, 57.9, 57.6, 56.8, 52.8, 51.3, 
50.8, 35.3, 28.4. 
 
ESI-MS: m/z: calculated for C16H24N8O5 [M+Na]+ 431; found 431 (100%).  
 
Elemental analysis calculated for C16H24N8O5 (408.19): C 47.05, H 5.92, N 27.44; found: C 47.20, H 
5.89, N 27.31. 
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6.4.3.3 Acetyl-di-(4S)-azidoproline methyl ester 20 
 
CO2CH3
N3
N
O
N3
N
Ac
 
Boc-di-(4S)-azidoproline methyl ester (98 mg, 0.24 mmol) was Boc-deprotected 
following the general procedure. The HCl salt was reacted withacetic anhydride (62 µL, 
0.66 mmol) and pyridine (197 µL, 1.32 mmol) in dry CH2Cl2 (1 mL) at room 
temperature for 30 min. The reaction mixture was diluted with CH2Cl2 (10 mL) and was 
extracted with 2N HCl. The aqueous layer was extracted two additional times with 
CH2Cl2 (10 mL). The combined organic layers were dried and the solvent was removed 
in vacuo. The crude product was purified by column chromatography (gradient 
CH2Cl2:MeOH 100:0 to 96:4), yielding 20 (77 mg, 0.034 mol 60%). 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 4.68 (dd, J = 8.8 Hz, 4.6 Hz, 1H; Hα), 4.52 (dd, J = 7.9 Hz, 6.8 
Hz, 1H; Hα), 4.29 (m, 1H; Hγ), 4.17 (dd, J = 10.4 Hz, 6.2 Hz, 1H; Hδ), 4.13 (m, 1H; Hγ), 3.84 (dd, J = 
10.2 Hz, 7.2 Hz, 1H; Hδ), 3.72 (s, 3H; OCH3), 3.50 (m, 1H; Hδ), 3.47 (dd, J = 10.4 Hz; 4.1 Hz 1H; Hδ), 
2.61 (m, 1H; Hβ), 2.46 (ddd, J = 13.4 Hz, 8.8 Hz, 5.8 Hz, 1H; Hβ), 2.16 (m, 1H; Hβ), 2.12 (m, 1H; Hβ), 
2.05 (s, 3H; Ac-CH3). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 171.0, 169.6, 169.1, 59.4, 58.4, 57.2, 56.0, 52.5, 52.0, 51.4, 33.9, 
33.8, 22.1. 
 
ESI-MS: m/z: calcd for C13H18N8O4 [M+Na]+ 373; found 373 (60%); [2M+Na]+ 723; found 723 (100%). 
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6.4.3.4 Acetyl-di-(4R)-azidoproline methyl ester 21 
 
CO2CH3
N3
N
O
N3
N
Ac
 
 
Acetyl-di-(4R)-azidoproline methyl ester was prepared analogously to 
Acetyl-di-(4S)-azidoproline methyl ester 20.  
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 4.65 (dd, J = 8.0 Hz, 5.9 Hz, 1H; Hα), 4.61 (dd, J = 8.1 Hz, 6.5 
Hz, 1H; Hα), 4.45 (m, 1H; Hγ), 4.32 (m, 1H; Hγ), 4.07 (dd, J = 10.3 Hz, 4.4 Hz, 1H; Hδ), 3.88 (dd, J = 
10.7 Hz, 5.8 Hz, 1H; Hδ), 3.85 (m, 1H; Hδ), 3.74 (s, 3H; OCH3), 3.48 (dd, J = 10.7 Hz; 3.8 Hz 1H; Hδ), 
2.31 (m, 2H; Hβ), 2.20 (m, 1H; Hβ), 2.06 (s, 3H; Ac-CH3). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 172.0, 170.6, 169.3, 59.8, 59.5, 57.6, 56.0, 52.8, 52.5, 51.6, 34.5, 
34.3, 22.1. 
 
ESI-MS: m/z: calcd for C13H18N8O4 [M+Na]+ 373; found 373 (60%); [2M+Na]+ 723; found 723 (100%). 
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6.5 Synthesis of the cyclotriproline scaffold and derivatives 
6.5.1 Boc-[Pro(4S)-N3]3-OCH3 35 
 
O
N
N3
N
O
N3
N
O
O
O
O
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The methyl ester of the dipeptide 31 (504 mg, 1.224 mmol) was hydrolysed, converted 
into a Pfp-ester and coupled with the HCl salt 30 (253 mg, 1.224 mmol) following the 
general procedures. Purification by flash chromatography on silica gel (gradient of 
EtOAc:pentane from 1:1 to 3:1) yielded the tripeptide 35 (486 mg, 0.889 mmol, 73%) 
as a colorless oil.  
 
1H and 13C NMR show multiple sets of peaks due to the s-trans and s-cis conformers. 1H NMR (500 
MHz, CDCl3, 25°C): δ = 4.72-4.35 (m, 3H, Hα), 4.28 (m, 1H, Hγ), 4.15 (m, 3H, Hγ, Hδ), 4.03 (m, 1H, 
Hγ), 3.85-3.73 (m, 1H, Hδ), 3.72 (s, 3H, CH3), 3.52-3-39 (m, 2H, Hδ), 3.35-3.28 (m, 1H, Hδ), 2.67-2.40 
(m, 3H, Hβ), 2.22-1.98 (m, 3H, Hβ) 1.41-1.37 (2s, 9H, tbu). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 171.1, 170.5, 170.0, 169.7, 169.5, 154.1, 153.0, 80.6, 80.4, 59.7, 
58.9, 58.5, 57.8, 57.4, 57.3, 56.7, 56.3, 51.6, 50.8, 35.0, 34.09, 34.07, 33.3, 28.4, 52.6, 51.6, 51.3, 51.1. 
 
ESI-MS: m/z: calculated for C21H30N12O6 [M+Na]+ 569; found 569 (100%). 
 
Elemental analysis calculated for C21H30N12O6 (546,54): C 46.15, H 5.53, N 30.75; found: C 46.10, H 
5.58, N 30.65. 
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6.5.2 Boc[Pro-(4S)-N3]3-OH  
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N
N3
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O
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The methyl ester of the tripeptide 35 (465 mg, 0.851 mmol) was saponified, following 
the general procedure. Purification by flash chromatography on silica gel (gradient of 
CH2Cl2/AcOH/MeOH from 98.5/1/0.5 to 97/1/2) yielded the tripeptide (439 mg,  
0.824 mmol, 97%) as a colorless oil.  
 
1H and 13C NMR show multiple sets of peaks due to the s-trans and s-cis conformers. 1H-NMR (500 
MHz, CDCl3, 25°C): δ = 4.72-4.45 (m, 3H, Hα), 4.42-4.17 (m, 2H, Hγ), 4.17-4.10 (m, 2H, Hδ), 4.10-3.98 
(m, 1H, Hγ), 3.87-3.32 (m, 4H, Hδ), 2.67-2.01 (m, 6H, Hβ), 1.46-1.38 (2s, 9H, tbu) 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 172.4, 172.3, 171.3, 170.3, 154.3, 153.1, 81.0, 80.7, 59.6, 58.9, 
58.6, 58.3, 57.9, 56.9, 56.5, 52.2, 51.4, 51.2, 51.0, 35.0, 34.1, 33.4, 33.2, 28.5, 28.4 
 
ESI-MS: m/z: calculated for C20H28N12O6 [M+Na]+ 555; found 555 (100%), 533 (40%, [M+H]+), 433 
(25%, [M–Boc+H]+). 
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6.5.3 HCl•H-[(4S)-N3-L-Pro]3-OH 36  
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The Boc-protecting group of Boc[Pro-(4S)-N3]3-OH (498 mg, 0.935 mmol) was 
removed following the general procedure to yield the HCl-salt 36 (438 mg, 0.935 mmol, 
quant.) as a white solid that was used without further purification.  
 
1H and 13C NMR show multiple sets of peaks due to the s-trans and s-cis conformers. 
1H NMR (500 MHz, CD3OD, 25°C): δ = 4.82-4.58 (m, 3H, Hα), 4.58-4.30 (m, 3H, Hγ), 4.15-3.35 (m, 
6H, Hδ), 2.95-1.95 (6H, Hβ);  
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 174.5, 173.7, 172.2, 171.0, 170.8, 168.2, 167.4, 61.0, 60.8, 60.5, 
60.3, 60.0, 59.7, 59.5, 59.3, 59.1, 59.0, 58.9, 58.6, 58.5, 53.6, 53.5, 53.3, 52.7, 52.6, 52.3, 51.7, 37.4, 37.1, 
36.9, 35.8, 35.6, 35.0, 34.9, 34.3. 
 
ESI-MS: m/z: calculated for C15H20N12O4 [M+H]+ 433; found 433 (100%). 
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6.5.4 cyclo[Pro-(4S)-N3]3 34  
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The HCl-salt 36 (438 mg, 0.935 mmol) was dissolved in anhydrous DMF (17 mL) and 
added within 1 h via syringe pump to a stirred solution of HATU (1.066 g, 2.805 mmol) 
and Hünig`s base (1.44 mL, 8.428 mmol) in anhydrous DMF (90 mL). The reaction 
mixture was stirred for an additional hour before removal of all volatiles at reduced 
pressure. The remaining oil was extracted with CH2Cl2 (100 mL) and 2M HCl (50 mL). 
The aqueous layers were extracted with CH2Cl2 (2×50 mL), the organic layers were 
washed with brine and dried over Na2SO4. Filtration and evaporation of the solvent at 
reduced pressure followed by flash chromatography on silica gel (EtOAc) yielded the 
cyclotripeptide 34 (284 mg, 0.685 mmol, 73%) as a white solid.  
 
1H NMR (500 MHz, CDCl3, 25°C); δ = 5.07 (dd, J = 8.1 Hz, 2.1 Hz, 3H; Hα), 4.52 (dd, J = 12.5 Hz, 8.1 
Hz, 3H; Hδ), 4.04 (dtd, J = 9.9 Hz, 8.1 Hz, 5.3 Hz, 3H; Hγ), 3.14 (dd,  
J = 12.5 Hz, 8.2 Hz, 3H; Hδ), 2.64 (ddd, J = 13.9 Hz, 5.2 Hz, 2.1 Hz, 3H; Hβ), 2.54 (ddd, J = 13.8 Hz, 
10.0 Hz, 8.2 Hz, 3H; Hβ). 
13C NMR (125 MHz, CDCl3, 25°C): δ = 165.9, 56.3, 55.7, 49.3, 34.1.  
 
FT-IR (NaCl, ν/cm-1): 2108, 1646, 1441, 1362, 1263, 1211.  
 
ESI-MS: m/z: calculated for C15H18N12O3 [M+Na]+ 437; found 437 (100%).  
 
Elemental analysis calculated for C15H18N12O3 (414.16): C 43.48, H 4.38, N 40.56, found: C 43.41, H 
4.34, N 40.50. 
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6.5.5 cyclo[Pro(4S)NHAc]3 33  
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Palladium on carbon (10%, 3 mg) was added to the solution of the triazide 36 (10 mg, 
24 µmol) in a 1:2 mixture of THF:MeOH (2 mL). The black suspension was evacuated, 
flushed with hydrogen and allowed to stir for 2 h at room temperature. After filtration 
over celite and removal of the solvent at reduced pressure, the residue was dissolved in 
THF, acetic anhydride (35 µL, 360 µmol) and polyvinylpyridine (10 mg) were added 
and the reaction mixture was stirred for 1 h. After filtration and removal of all volatiles 
at reduced pressure the residue was triturated with Et2O (2×10 mL) to afford the 
acetylated cyclotriproline 33 (7 mg, 15 µmol, 63%) as a white solid.  
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 7.67 (d, J = 9.5 Hz, 3H; NH), 5.15 (d, J = 7.4 Hz, 3H; Hα), 4.93 
(dq, J = 8.7 Hz, 4.1 Hz, 3H; Hγ), 4.37 (dd, J = 13.7 Hz, 8.7 Hz, 3H; Hδ), 3.04 (dd, J = 13.7 Hz, 4.1 Hz, 
3H; Hδ'), 2.50 (m, 3H; Hβ), 2.18 (d, J = 14.0 Hz, 3H; Hβ'), 2.03 (s, 9H; AcCH3). 
 
13C NMR (100.5 MHz, CDCl3, 25°C): δ = 169.6, 167.1, 57.6, 53.7, 44.5, 36.5, 23.5. 
 
ESI-MS: m/z: calculated for C21H30N6O6 [M+Na]+ 485; found 485 (100%). 
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6.5.6 cyclo[Pro-(4R)-N3]3 40 
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40 was prepared in analogy to 34 and isolated as a white solid in approximately 15% 
yield. 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 5.15 (d, J = 6.9 Hz, 3H; Hα), 4.86 (qd, J = 7.4 Hz, 3.8 Hz, 3H; 
Hγ´), 3.87 (dd, J = 13.2 Hz, 3.8 Hz, 3H; Hδ´), 3.55 (dd, J = 13.2 Hz, 7.4 Hz, 3H; Hδ), 2.86 (ddd, J = 13.3 
Hz, 7.5 Hz, 1.1 Hz, 3H; Hβ´), 2.06 (ddd, J = 13.4 Hz, 7.4 Hz, 6.9 Hz, 3H; Hβ). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 166.3, 58.7, 56.8, 51.1, 35.0. 
FT-IR (KBr): ν = 3345, 2930, 2109, 1653, 1628, 1437, 1356, 1317, 1269. 
 
ESI-MS: m/z: calculated for C15H18N12O3 [M+Na]+ 437; found 437 (100%).  
 
Elemental analysis calculated for C15H18N12O3 (414.16): C 43.48, H 4.38, N 40.56, found: C 43.47, H 
4.26, N 40.44. 
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6.5.7 cyclo[Pro-(4R)-NHAc]3 32 
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32 was prepared in analogy to 33 and isolated as a white solid in 64% yield.  
 
1H NMR (400 MHz, CD3OD, 25°C): δ = 5.55 (d, J = 7.2 Hz, 3H; Hα), 4.93 (dq, J = 5.1 Hz, 8.1 Hz, 3H; 
Hγ), 3.65 (dd, J = 12.9 Hz, 5.1 Hz, 3H; Hδ´), 3.57 (dd, J = 12.9 Hz, 8.5 Hz, 3H; Hδ), 2.68 (dd, J = 12.9 
Hz, 8.1 Hz, 3H; Hβ´), 1.97 (dt, J = 12.9 Hz, 7.7 Hz, 3H; Hβ), 1.93 (s, 9H; CH3).  
 
13C NMR (100.5 MHz, CD3OD, 25°C): δ = 171.0, 167.1, 56.2, 50.3, 47.0, 34.6, 20.8. 
 
ESI-MS: m/z: calculated for C21H30N6O6 [M+Na]+ 485; found 485 (100%). 
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6.6 Synthesis of the receptor prototype 
6.6.1 Cyclotriproline-Tyr(DR)-Boc 42 
N
O
3
NH
O
NHBoc
O
DR  
Cyclo[(4S)-N3-L-Pro]3 34 (23 mg, 0.056 mmol) was suspended in dry THF (0.5 mL).  
1 M trimethylphosphine in THF (0.27 mL, 0.27 mmol) was added and the reaction was 
stirred at room temperature. After 10 minutes H2O (0.27 mL) were added. The reaction 
was stirred for 2 hours, then the solvent was removed and the residual solid was 
coevaporated with toluene (5×3 mL). The residual, off-white solid was reacted with 
Boc-Tyr(DR)-OH (146 mg, 0.252 mmol), HATU (128 mg, 0.337 mmol) and Hünig's 
base (172 µL, 1.0 mmol) in dry DMF (0.5 mL). After 2 hours the reaction mixture was 
diluted with CH2Cl2 (10 mL) and extracted with 1N HCl (5 mL). The aqueous layer was 
extracted again with CH2Cl2 (10 mL). The combined organic layers were dried and the 
solvent was removed in vacuo. The crude product was purified by column 
chromatography (gradient CH2Cl2:MeOH 100:0 to 90:10), and gel filtration (LH20, 
CH2Cl2:MeOH 90:10) yielding cyclotriproline-Tyr(DR)-Boc 42 (68 mg, 0.22 mol, 
60%). 
1H NMR (500 MHz, CDCl3, 25°C): δ = 8.28 (m, 2H; ar), 8.09 (d, J = 9.3 Hz, 1H; NH), 7.88 (m, 4H; ar), 
7.08 (d, J = 8.5 Hz, 2H; ar), 6.78 (m, 4H; ar), 5.21 (d, J = 6.5 Hz, 1H; Pro-Hα), 4.95 (d, J = 7.1 Hz, 1H; 
NHcarb), 4.81 (m, 1H; Pro-Hγ), 4.31 (m, 2H; Tyr-Hα, Pro-Hδ), 4.12 (t, J = 5.7 Hz, 2H; CH2), 3.57 (q, J = 
7.1 Hz, 2H; CH2CH3), 3.04 (dd, J = 14.1 Hz, 5.5 Hz, 1H; Tyr-Hβ), 2.91 (m, 2H; Pro-Hδ, Tyr-Hβ), 2.42 
(m, 1H; Pro-Hβ), 2.08 (d, J = 13.9 Hz, 1H; Pro-Hβ), 1.37 (s, 9H; tBu), 1.25 (t, J = 7.1 Hz, 3H; CH2CH3). 
13C NMR (125 MHz, CDCl3, 25°C): δ = 170.7, 167.1, 157.4, 156.7, 155.2, 151.2, 147.3, 143.6, 130.4, 
129.0, 126.2, 124.6, 122.6, 114.5, 111.4, 79.9, 65.3, 57.5, 55.6, 53.4, 49.8, 46.1, 44.7, 37.5, 36.0, 29.6, 
28.3, 12.2. 
 
ESI-MS: m/z: calculated for C105H123N21O21 [M+Na]+ 2037; found 2037 (100%); [1/2M+Na]+ 1030, 
found 1030 (90%). 
6.6  Synthesis of the receptor prototype 91 
6.6.2 Cyclotriproline-Tyr(DR)-Asp(tbu)-Fmoc 43 
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Cyclotriproline-Tyr(DR)-Boc (23 mg, 0.011 mmol) was Boc-deprotected using the 
general procedure. The hydrochloride salt was reacted with Fmoc-Asp(tbu)-OH (27 mg, 
0.066 mmol), EDC (13 mg, 0.069 mmol), and Hünig's base (13 µL, 0.077 mmol) in dry 
CH2Cl2 (0.25 mL). After 1 hour the reaction mixture was diluted with CH2Cl2 (5 mL) 
and extracted with 1N HCl (5 mL). The aqueous layer was extracted again with CH2Cl2 
(5 mL). The combined organic layers were dried and the solvent was removed in vacuo. 
The crude product was purified by column chromatography (gradient CH2Cl2:MeOH 
100:0 to 90:10), and gel filtration (LH20, CH2Cl2:MeOH 90:10) yielding 43 (29 mg, 
0.01 mol, 91%) as pure product. 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 8.30 (m, 2H; ar), 8.20 (d, J = 9 Hz, 1H; NH), 7.88 (m, 2H; ar), 
7.83 (m, 2H; ar), 7.74 (m, 2H; ar), 7.57 (m, 2H; ar), 7.38 (m, 2H; ar), 7.29 (m, 2H; ar), 7.05 (m, 2H; ar), 
6.88 (d, J = 7.7 Hz, 1H; NH), 6.69 (m, 4H; ar), 6.01 (d, J = 8.7 Hz, 1H; NH), 5.00 (d, J = 7.9 Hz, 1H; 
Pro-Hα), 4.77 (m, 1H; Pro-Hγ), 4.57 (m, 2H; Asp-Hα, Tyr-Hα), 4.40 (dd, J = 10.5 Hz, 6.9 Hz, 1H; 
CH2Fmoc), 4.31 (m, 2H; Pro-Hδ, CH2Fmoc), 4.18 (t, J = 7.1 Hz, 1H; CHFmoc), 3.93 (m, 2H; CH2dye), 
3.67 (m, 2H; CH2dye), 3.47 (q, J = 7.0 Hz, 2H; CH2CH3), 3.04 (m, 2H; Asp-Hβ), 2.89 (m, 2H; Pro-Hβ, 
Tyr-Hβ), 2.65 (m, 1H; Tyr-Hβ), 2.31 (m, 1H; Pro-Hβ), 2.00 (d, J = 13.9 Hz, 1H; Pro-Hβ), 1.40 (s, 9H; 
tBu), 1.18 (t, J = 7.1 Hz, 3H; CH2CH3dye). 
13C NMR (125 MHz, CDCl3, 25°C): δ = 171.4, 170.4, 169.6, 166.8, 157.4, 156.7, 156.1, 151.2, 147.3, 
143.8, 143.6, 143.5, 141.2, 130.4, 127.8, 127.1, 126.2, 125.2, 125.0, 124.6, 122.6, 120.0, 114.4, 111.3, 
81.7, 67.3, 65.1, 57.5, 54.5, 53.6, 51.1, 49.7, 47.0, 46.0, 44.6, 36.7, 36.5, 36.2, 28.0, 12.2.  
ESI-MS: m/z: calculated for C159H168N24O30 [M+Na]+ 2915; found 2915 (100%). 
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6.6.3 Cyclotriproline-Tyr(DR)-Asp(tbu)-Asp(tbu)-Fmoc 44 
N
O
3
NH
O
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O
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O
NH
O
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CO2t-Bu
t-BuO2C
 
Cyclotriproline-Tyr(DR)-Asp-Fmoc (29 mg, 0.01 mmol) was Fmoc-deprotected 
following the general procedure. The free amine was reacted with Fmoc-Asp(tbu)-OH 
(25 mg, 0.06 mmol) and EDC (12 mg 0.063 mmol) in dry CH2Cl2 (0.25 mL). After  
1 hour the reaction mixture was diluted with CH2Cl2 (5 mL) and extracted with 1N HCl  
(5 mL). The aqueous layer was extracted again with CH2Cl2 (5 mL). The combined 
organic layers were dried and the solvent was removed in vacuo. The crude product was 
purified by column chromatography (gradient CH2Cl2:MeOH 100:0 to 90:10), and gel 
filtration (LH20, CH2Cl2:MeOH 90:10) yielding 44 (21 mg, 0.061 mol 61%). 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 8.30 (m, 2H; ar), 8.13 (d, J = 9.1 Hz, 1H; NH), 7.87 (m, 4H; ar), 
7.74 (m, 2H; ar), 7.55 (m, 2H; ar), 7.38 (m, 2H; ar), 7.28 (m, 2H; ar), 7.18 (d, J = 7.7 Hz, 1H; NH), 7.08 
(m, 2H; ar), 6.77 (m, 4H; ar), 5.86 (d, J = 8.2 Hz, 1H; NH), 4.98 (d, J = 7.6 Hz, 1H; Pro-Hα), 4.79 (m, 
1H; Tyr-Hα), 4.72 (m, 1H; Pro-Hγ), 4.47 (m, 1H; Asp1-Hα), 4.43-4.28 (m, 4H; Pro-Hδ, Asp2-Hα, 
CH2Fmoc), 4.20 (t, J = 7.1 Hz, 1H; CHFmoc), 4.08 (m, 2H; CH2dye), 3.76 (m, 2H; CH2dye), 3.54 (q, J = 
6.9 Hz, 2H; CH2CH3), 3.14 (dd, J = 14.0 Hz, 5.0 Hz, 2H; Asp1-Hβ), 3.00-2.78 (m, 4H; Pro-Hδ, Asp1-Hβ, 
Asp2-Hβ, Tyr-Hβ), 2.69 (m, 1H; Asp2-Hβ), 2.55 (m, 1H; Tyr-Hβ), 2.30 (m, 1H; Pro-Hβ), 2.01 (d, J = 
14.0 Hz, 1H; Pro-Hβ), 1.43 (s, 9H; tBu), 1.32 (s, 9H; tBu), 1.22 (t, J = 6.9 Hz, 3H; CH2CH3dye). 
13C NMR (125 MHz, CDCl3, 25°C): δ = 171.3, 171.1, 170.7, 170.3, 170.0, 167.0, 157.4, 156.9, 156.2, 
151.4, 147.4, 143.8, 143.7, 141.4, 141.3, 130.4, 129.7, 128.0, 127.3, 127.2, 126.4, 125.2, 124.8, 122.7, 
120.2, 114.6, 111.5, 82.2, 81.8, 67.2, 65.3, 57.6, 55.2, 51.8, 49.9, 49.7, 47.1, 46.2, 44.9, 36.3, 36.2, 29.8, 
28.2, 28.1, 12.4. 
ESI-MS: m/z: calculated for C183H207N27O39 [M+Na]+ 3429; found 3429 (100%). 
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6.6.4 Cyclotriproline-Tyr(DR)-Asp(tbu)-Asp(tbu)-Ac 45 
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Cyclotriproline-Tyr(DR)-Asp-Fmoc (18 mg, 0.0053 mmol) was Fmoc-deprotected 
following the general procedure. The free amine was reacted with acetic acid (45 µL, 
0.792 mmol), which had been preactivated by mixing with HCTU (393mg, 0.950 
mmol) and Hünig's base (0.5 mL, 2.85 mmol) in dry DMF (0.3 mL). After 1 hour, the 
reaction mixture was diluted with CH2Cl2 (5 mL) and extracted with 1N HCl (5 mL). 
The aqueous layer was extracted again with CH2Cl2 (5 mL). The combined organic 
layers were dried and the solvent was removed in vacuo. The crude product was 
purified by column chromatography (gradient CH2Cl2:MeOH 100:0 to 90:10), and gel 
filtration (LH20, CH2Cl2:MeOH 90:10) yielding pure 45 (8 mg, 0.0027 mol, 50%). 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 8.32 (m, 2H; ar), 8.13 (d, J = 9 Hz, 1H; NH), 7.90 (m, 4H; 
ar),7.43 (d, J = 8.3 Hz, 1H; NH), 7.12 (m, 2H; ar), 6.80 (m, 4H; ar), 6.73 (d, J = 7.9 Hz, 1H; NH), 5.06 (d, 
J = 7.3 Hz, 1H; Pro-Hα), 4.81-4.68 (m, 2H; Tyr-Hα, Pro-Hγ), 4.60 (m, 1H; Asp1-Hα), 4.42 (m, 1H; 
Asp2-Hα), 4.33 (dd, J = 13.5 Hz, 8.5 Hz, 1H; Pro-Hδ), 4.14 (t, J = 5.7 Hz, 2H; CH2dye), 3.83 (t, J = 5.7 
Hz, 2H; CH2dye), 3.60 (q, J = 7.1 Hz, 2H; CH2CH3dye), 3.22 (dd, J = 14.2 Hz, 4.6 Hz, 1H; Asp2-Hβ), 
2.95 (m, 2H; Asp2-Hβ, Pro-Hδ), 2.73 (m, 3H; Tyr-Hβ, 2xAsp1-Hβ), 2.56 (m, 1H; Tyr-Hβ), 2.39 (m, 1H; 
Pro-Hβ), 2.04 (d, J = 14.0 Hz, 1H; Pro-Hβ), 1.97 (s, 3H; AcCH3), 1.41 (s, 9H; tBu), 1.33 (s, 9H; tBu), 
1.27 (t, J = 7.1 Hz, 3H; CH2CH3dye). 
13C NMR (125 MHz, CDCl3, 25°C): δ = 171.1, 171.0, 170.5, 170.4, 170.3, 170.1, 167.0, 157.2, 156.8, 
151.3, 147.3, 143.7, 130.2, 129.9, 126.3, 124.7, 122.6, 114.4, 111.4, 82.0, 81.6, 65.2, 57.5, 55.4, 53.0, 
49.9, 49.6, 46.2, 44.9, 36.7, 36.1, 35.8, 29.7, 28.0, 27.9, 23.0, 12.3. 
 
ESI-MS: m/z: calculated for C144H183N27O36 [M+Na]+ 2889; found 2889 (100%). 
 
94 6  Experimental Section 
Cyclotriproline-Tyr(DR)-Asp-Asp-Ac 46 
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Cyclotriproline-Tyr(DR)-Asp(tbu)-Asp(tbu)-Ac 45 (6 mg, 0.002 mmol) was treated with 
50% TFA in CH2Cl2 (2 mL) for 30 minutes at room temperature. After removal of all 
volatiles, the residual oil was triturated with pentanes to yield the deprotected receptor 
46 (2.6 mg, 0.001 mmol, 50%). 
 
1H NMR (500 MHz, CDCl3, 25°C): δ = 7.99 (m, 2H; ar), 7.57 (m, 4H; ar), 6.82 (m, 2H; ar),6.52 (m, 4H; 
ar), 5.08 (d, J = 8.0 Hz, 1H; Pro-Hα), 4.51 (t, J = 6.0 Hz, 1H; Tyr-Hα), 4.31 (m, 1H; Asp1-Hα), 4.25 (m, 
1H; Pro-Hδ), 4.10 (dd, J = 8.7 Hz, 5.3 Hz, 1H; Asp2-Hα), 4.00 (dd, J = 13.0 Hz, 8.2 Hz, 1H; Pro-Hδ), 
3.84 (t, J = 5.4 Hz, 2H; CH2dye), 3.53 (t, J = 5.4 Hz, 2H; CH2dye), 3.30 (q, J = 7.1 Hz, 1H; CH2CH3dye), 
2.83 (dd, J = 14.0 Hz, 5.8 Hz, 1H; Asp2-Hβ; Pro-Hδ), 2.67 (m, 1H; Asp2-Hβ), 2.59 (dd, J = 13.4 Hz, 4.4 
Hz, 1H; Pro-Hδ), 2.50 (m, 2H; Tyr-Hβ, Asp1-Hβ), 2.39 (m, 2H; Tyr-Hβ, Asp1-Hβ), 2.11 (m, 1H; Pro-
Hβ), 1.78 (d, J = 13.4 Hz, 1H; Pro-Hβ), 1.62 (s, 3H; AcCH3), 0.56 (t, J = 7.1 Hz, 3H; CH2CH3dye). 
 
13C NMR (125 MHz, CDCl3, 25°C): δ = 173.6, 172.6, 172.0, 171.6, 168.7, 158.1, 157.3, 152.3, 147.8, 
144.1, 130.8, 130.1, 127.0, 125.2, 123.0, 115.0, 112.2, 66.1, 57.8, 56.3, 50.5, 50.4, 40.5, 49.3, 49.2, 49.0, 
48.8, 48.7, 48.5, 36.2, 35.9, 35.5, 30.1, 22.6, 12.5. 
 
ESI-MS: m/z: calculated for C120H135N27O36 [M-3H]- 824; found 824 (100%). 
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7.2 Appendix A: List of Sequences found in the combinatorial 
screenings 
Sequences found in on-bead combinatorials screenings: 
0,01M NaHCO3 pH 8,5 
Position   
3. 2. 1. 
D-Ala D-Arg D-Arg 
D-Ala D-Arg L-Arg 
D-Ala L-Arg L-Pro 
D-Arg D-Arg D-Arg 
D-Arg D-Arg D-Lys 
D-Arg D-Arg D-Phe 
D-Arg D-Arg D-Val 
D-Arg D-Pro D-Arg 
D-Arg D-Thr D-Arg 
D-Arg Gly D-Arg 
D-Arg Gly (?) L-Arg 
D-Arg L-Arg D-Val 
D-Arg L-Asn D-Arg 
D-Arg L-Glu L-Arg 
D-Arg L-His D-Arg 
D-Asn D-Arg D-Arg 
D-Asn D-Arg L-Arg 
D-Asn L-Arg L-Arg 
D-Lys L-Arg L-Ser/L-Lys 
D-Pro D-Arg L-Pro 
D-Thr D-Arg L-Arg 
D-Thr L-Arg L-Arg 
L-Arg D-Arg ? 
L-Arg D-Arg D-Arg 
L-Arg D-Arg D-Arg 
L-Arg D-Arg D-Arg 
L-Arg D-Arg D-Thr 
L-Arg D-Asn D-Arg 
L-Arg D-Asn L-Arg 
L-Arg D-Gln L-Arg 
L-Arg D-Ser D-Arg 
L-Arg D-Ser D-Arg 
L-Arg D-Ser D-Arg 
L-Arg D-Thr L-Arg 
L-Arg D-Thr (?) D-Arg 
L-Arg Gly D-Arg 
L-Arg L-Arg L-Arg 
L-Gln D-Arg L-Arg 
L-Gln L-Arg L-Pro 
L-His D-Arg D-Arg 
L-His L-Arg D-Arg 
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L-Pro L-Arg D-Arg 
L-Val L-Arg D-Arg 
 
 
0,01M NaOH pH 12.0 
Position   
3. 2. 1. 
D-Arg ? ? 
D-Arg D-Arg D-Thr 
D-Arg D-Arg D-Val 
D-Arg D-Arg L-Ala 
D-Arg D-Arg L-Thr 
D-Arg D-Arg L-Val 
D-Arg D-Arg  D-Phe 
D-Arg Gly D-Arg 
D-Arg L-Arg L-Phe 
D-Arg L-Arg L-Phe 
D-Arg L-Glu D-Arg 
D-Arg L-Ser L-Arg 
D-Lys L-Arg L-Pro(?) 
D-Pro D-Arg D-Arg 
D-Thr L-Arg L-Arg 
D-Val L-Arg L-Arg 
L-Ala D-Arg L-Arg 
L-Arg D-Arg D-Leu 
L-Arg D-Arg D-Ser 
L-Arg D-Arg D-Thr 
L-Arg D-Arg D-Val 
L-Arg D-Arg L-Thr 
L-Arg D-Arg(?) L-Ala(?) 
L-Arg D-Ser L-Arg 
L-Arg L-Ala D-Arg(?) 
L-Arg L-Arg D-Arg 
L-Arg L-Arg D-Val 
L-Arg L-Arg D-Val 
L-Arg L-Arg L-Ala 
L-Arg L-Ser D-Ser(?) 
L-Arg L-Ser L-Arg(?) 
L-Arg (?) D-Ser L-Arg(?) 
L-Leu L-Arg L-Arg 
L-Thr L-Arg D-Arg 
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7.3 Appendix B: Crystallographic data 
 
Table 1: Crystal data for 15 
 
formula      C8H12N4O3 
formula weight     212.21 
Z, calculated density     4, 1.392 Mg m-3 
F(000)       448 
description and size of crystal: colorless plate, 0.10 · 0.22 · 0.23 mm3 
absorption coefficient     0.109 mm-1 
min/max transmission    0.98 / 0.99 
temperature      173K 
radiation(wavelength)    Mo Kα (λ = 0.71073 Å) 
Crystal system, space group    monoclinic, P 1 21 1  
a       9.2443(2) Å 
b       12.7360(2) Å 
c       9.4877(2) Å 
α       90° 
β       115.0156(8)° 
γ       90° 
V       1012.25(4) Å3 
min/max Θ      2.369° / 27.870° 
number of collected reflections   7874 
number of independent refections   2524 (merging r = 0.077) 
number of observed reflections   2226 (I>0.50σ(I)) 
number of refined parameters   271 
r       0.0390 
Rw       0.0495 
goodness of fit     0.9367 
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Bond distances Å 
C1 C2 1.541(3) 
C1 C7 1.515(3) 
C1 N1 1.460(3) 
C1 H11 0.984 
C2 C3 1.527(3) 
C2 H21 0.986 
C2 H22 0.985 
C3 C4 1.521(3) 
C3 N2 1.495(3) 
C3 H31 0.995 
C4 N1 1.471(3) 
C4 H42 0.992 
C4 H41 1.023 
C5 C6 1.498(3) 
C5 N1 1.349(3) 
C5 O1 1.235(3) 
C6 H61 1.020 
C6 H63 0.985 
C6 H64 0.978 
C7 O2 1.330(3) 
C7 O3 1.204(3) 
C8 O2 1.447(3) 
C8 H81 0.995 
C8 H82 0.990 
C8 H83 0.989 
C9 C10 1.540(3) 
C9 C15 1.522(3) 
C9 N5 1.457(3) 
C9 H91 0.980 
C10 C11 1.527(3) 
C10 H101 0.971 
C10 H102 0.987 
C11 C12 1.524(4) 
C11 N6 1.485(3) 
C11 H111 0.990 
C12 N5 1.458(3) 
C12 H121 0.992 
C12 H122 0.962 
C13 C14 1.504(3) 
C13 N5 1.350(3) 
C13 O4 1.229(3) 
C14 H141 0.990 
C14 H142 0.996 
C14 H143 0.972 
C15 O5 1.198(3) 
C15 O6 1.329(3) 
C16 O6 1.446(3) 
C16 H161 1.000 
C16 H162 1.000 
C16 H163 1.000 
106 7  References and Appendices 
N2 N3 1.226(3) 
N3 N4 1.133(3) 
N6 N7 1.223(3) 
N7 N8 1.127(3) 
 
Bond angles Deg 
C2 C1 C7 110.52(18) 
C2 C1 N1 103.09(16) 
C7 C1 N1 110.72(18) 
C2 C1 H11 111.864 
C7 C1 H11 108.237 
N1 C1 H11 112.383 
C1 C2 C3 104.55(18) 
C1 C2 H21 108.752 
C3 C2 H21 109.838 
C1 C2 H22 110.284 
C3 C2 H22 115.580 
H21 C2 H22 107.675 
C2 C3 C4 103.4(2) 
C2 C3 N2 113.9(2) 
C4 C3 N2 106.16(19) 
C2 C3 H31 112.796 
C4 C3 H31 111.378 
N2 C3 H31 108.893 
C3 C4 N1 102.62(19) 
C3 C4 H42 110.883 
N1 C4 H42 109.975 
C3 C4 H41 110.575 
N1 C4 H41 110.564 
H42 C4 H41 111.860 
C6 C5 N1 117.04(19) 
C6 C5 O1 122.7(2) 
N1 C5 O1 120.3(2) 
C5 C6 H61 114.639 
C5 C6 H63 107.135 
H61 C6 H63 108.710 
C5 C6 H64 110.704 
H61 C6 H64 109.025 
H63 C6 H64 106.265 
C1 C7 O2 111.08(18) 
C1 C7 O3 124.5(2) 
O2 C7 O3 124.3(2) 
O2 C8 H81 115.739 
O2 C8 H82 111.988 
H81 C8 H82 102.563 
O2 C8 H83 116.392 
H81 C8 H83 104.276 
H82 C8 H83 104.349 
C10 C9 C15 111.59(19) 
C10 C9 N5 102.86(17) 
C15 C9 N5 112.33(17) 
C10 C9 H91 108.961 
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C15 C9 H91 110.259 
N5 C9 H91 110.600 
C9 C10 C11 103.18(17) 
C9 C10 H101 110.494 
C11 C10 H101 111.221 
C9 C10 H102 109.786 
C11 C10 H102 112.520 
H101 C10 H102 109.495 
C10 C11 C12 103.98(18) 
C10 C11 N6 110.60(19) 
C12 C11 N6 110.0(2) 
C10 C11 H111 110.471 
C12 C11 H111 109.718 
N6 C11 H111 111.774 
C11 C12 N5 104.69(18) 
C11 C12 H121 110.612 
N5 C12 H121 109.686 
C11 C12 H122 113.210 
N5 C12 H122 109.947 
H121 C12 H122 108.627 
C14 C13 N5 117.3(2) 
C14 C13 O4 122.0(2) 
N5 C13 O4 120.7(2) 
C13 C14 H141 111.735 
C13 C14 H142 109.221 
H141 C14 H142 106.937 
C13 C14 H143 108.710 
H141 C14 H143 110.339 
H142 C14 H143 109.876 
C9 C15 O5 125.5(2) 
C9 C15 O6 109.73(18) 
O5 C15 O6 124.8(2) 
O6 C16 H161 109.501 
O6 C16 H162 109.485 
H161 C16 H162 109.476 
O6 C16 H163 109.413 
H161 C16 H163 109.476 
H162 C16 H163 109.476 
C4 N1 C1 113.12(18) 
C4 N1 C5 127.15(19) 
C1 N1 C5 119.71(17) 
C3 N2 N3 115.3(2) 
N2 N3 N4 173.5(3) 
C12 N5 C9 112.36(18) 
C12 N5 C13 120.0(2) 
C9 N5 C13 127.50(18) 
C11 N6 N7 115.5(2) 
N6 N7 N8 172.3(3) 
C8 O2 C7 116.02(18) 
C16 O6 C15 116.79(18) 
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Table 2: Crystal data for 34 
 
formula      C15H18N12O3  
formula weight     414.39 
Z, calculated density     4, 1.453 Mg · m-3 
F(000)       864.300 
description and size of crystal   colorless  plate , 0.10 0.22 0.50 mm3 
absorption coefficient     0.109 mm-1 
min/max transmission    0.98 / 0.99 
temperature      293K 
radiation(wavelength)    Mo Kα (λ = 0.71073 Å) 
Crystal system, space group    orthorhombic , P 21 21 21  
a       10.842(1) Å 
b       11.840(5) Å 
c       14.757(7) Å 
α       90° 
β       90° 
γ       90° 
V       1894.3 Å3 
min/max Θ      4.13° / 27.57° 
number of collected reflections   13264 
number of independent refections   4271 (merging r = 0.12) 
number of observed reflections   2914 (>2.00σ(I)) 
number of refined parameters   272 
r       0.0449 
rW       0.0480 
goodness of fit     1.0616 
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Bond distances Å 
O1 C1 1.222(3) 
O2 C6 1.213(3) 
O3 C11 1.217(3) 
N1 C1 1.342(3) 
N1 C2 1.463(3) 
N1 C5 1.470(3) 
N2 C6 1.345(3) 
N2 C7 1.463(3) 
N2 C10 1.465(3) 
N3 C11 1.332(3) 
N3 C12 1.456(3) 
N3 C15 1.472(3) 
N4 N5 1.202(4) 
N4 C3 1.483(4) 
N5 N6 1.128(4) 
N7 N8 1.212(4) 
N7 C8 1.466(4) 
N8 N9 1.132(4) 
N10 N11 1.231(4) 
N10 C13 1.468(3) 
N11 N12 1.123(4) 
C1 C15 1.535(3) 
C2 C3 1.519(5) 
C2 H21 1.000 
C2 H22 1.000 
C3 C4 1.514(5) 
C3 H31 1.000 
C4 C5 1.533(3) 
C4 H41 1.000 
C4 H42 1.000 
C5 C6 1.532(3) 
C5 H51 1.000 
C7 C8 1.512(4) 
C7 H71 1.000 
C7 H72 1.000 
C8 C9 1.542(4) 
C8 H81 1.000 
C9 C10 1.522(3) 
C9 H91 1.000 
C9 H92 1.000 
C10 C11 1.527(3) 
C10 H101 1.000 
C12 C13 1.514(3) 
C12 H121 1.000 
C12 H122 1.000 
C13 C14 1.532(4) 
C13 H131 1.000 
C14 C15 1.532(3) 
C14 H141 1.000 
C14 H142 1.000 
C15 H151 1.000 
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Bond Angles Deg 
C1 N1 C2 121.4(2) 
C1 N1 C5 127.6(2) 
C2 N1 C5 108.0(2) 
C6 N2 C7 122.0(2) 
C6 N2 C10 127.68(19) 
C7 N2 C10 110.03(18) 
C11 N3 C12 122.87(18) 
C11 N3 C15 128.14(18) 
C12 N3 C15 108.67(16) 
N5 N4 C3 115.2(3) 
N4 N5 N6 173.0(4) 
N8 N7 C8 116.1(2) 
N7 N8 N9 173.9(3) 
N11 N10 C13 116.0(2) 
N10 N11 N12 172.2(3) 
O1 C1 N1 121.9(2) 
O1 C1 C15 120.0(2) 
N1 C1 C15 117.9(2) 
N1 C2 C3 100.9(2) 
N1 C2 H21 111.58(15) 
C3 C2 H21 111.57(15) 
N1 C2 H22 111.58(13) 
C3 C2 H22 111.59(16) 
H21 C2 H22 109.467 
N4 C3 C2 113.1(3) 
N4 C3 C4 109.1(3) 
C2 C3 C4 104.5(2) 
N4 C3 H31 105.76(18) 
C2 C3 H31 110.29(15) 
C4 C3 H31 114.31(18) 
C3 C4 C5 105.6(2) 
C3 C4 H41 110.44(15) 
C5 C4 H41 110.44(15) 
C3 C4 H42 110.44(18) 
C5 C4 H42 110.43(16) 
H41 C4 H42 109.467 
N1 C5 C4 104.1(2) 
N1 C5 C6 109.66(19) 
C4 C5 C6 110.8(2) 
N1 C5 H51 113.25(12) 
C4 C5 H51 112.19(16) 
C6 C5 H51 106.88(12) 
O2 C6 N2 121.2(2) 
O2 C6 C5 121.5(2) 
N2 C6 C5 117.36(19) 
N2 C7 C8 103.9(2) 
N2 C7 H71 110.83(14) 
C8 C7 H71 110.82(15) 
N2 C7 H72 110.85(13) 
C8 C7 H72 110.87(14) 
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H71 C7 H72 109.467 
N7 C8 C7 108.5(2) 
N7 C8 C9 113.3(2) 
C7 C8 C9 106.19(18) 
N7 C8 H81 106.55(13) 
C7 C8 H81 113.60(15) 
C9 C8 H81 108.84(13) 
C8 C9 C10 106.59(19) 
C8 C9 H91 110.18(14) 
C10 C9 H91 110.18(13) 
C8 C9 H92 110.20(13) 
C10 C9 H92 110.18(13) 
H91 C9 H92 109.467 
N2 C10 C9 103.39(18) 
N2 C10 C11 108.11(17) 
C9 C10 C11 111.87(18) 
N2 C10 H101 115.03(12) 
C9 C10 H101 111.46(13) 
C11 C10 H101 107.02(11) 
O3 C11 N3 121.3(2) 
O3 C11 C10 119.7(2) 
N3 C11 C10 118.95(18) 
N3 C12 C13 102.53(19) 
N3 C12 H121 111.16(11) 
C13 C12 H121 111.16(13) 
N3 C12 H122 111.20(11) 
C13 C12 H122 111.19(13) 
H121 C12 H122 109.467 
N10 C13 C12 114.0(2) 
N10 C13 C14 115.7(2) 
C12 C13 C14 105.71(18) 
N10 C13 H131 100.44(14) 
C12 C13 H131 111.46(13) 
C14 C13 H131 109.60(13) 
C13 C14 C15 106.2(2) 
C13 C14 H141 110.28(14) 
C15 C14 H141 110.28(13) 
C13 C14 H142 110.27(13) 
C15 C14 H142 110.27(14) 
H141 C14 H142 109.467 
N3 C15 C1 107.72(18) 
N3 C15 C14 102.85(18) 
C1 C15 C14 111.74(19) 
N3 C15 H151 115.54(11) 
C1 C15 H151 107.21(14) 
C14 C15 H151 111.77(15) 
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